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ABSTRACT OF DISSERTATION 
EXAMINING BIOLOGICAL AND PSYCHOLOGICAL VARIABLES IN 
HYPERTENSIVE DISORDERS OF PREGNANCY 
Despite advances in obstetric care, hypertensive disorders continue to complicate 
pregnancies at a high rate.  Worldwide, hypertensive disorders affect up to 10% of 
pregnancies. The United States has seen a 25% increase in the incidence of hypertensive 
disorders over the last two decades (American College of Obstetricians and 
Gynecologists, 2017). These complications constitute one of the greatest causes of 
maternal and perinatal morbidity and mortality with an estimated 50,000 to 60,000 deaths 
per year across the world (American College of Obstetricians and Gynecologists, 2017). 
Although the etiology of hypertensive disorders remains unclear, there may be an 
association with both maternal biological and psychological distress in the development 
of the disorder. Although both distress and biomarkers have been identified in association 
with a hypertensive disorder, little data exist examining the components of distress and 
the alterations in biomarkers in women developing these disorders. Due to the limited 
evidence, a critical need exists to examine the relationship of perceived maternal distress 
and biomarker measures in the development of a hypertensive disorder during pregnancy 
in order to better understand this phenomenon. 
The purposes of this dissertation were to: 1) understand the experience of having 
a hypertensive disorder during pregnancy; 2) to investigate the association of perceived 
stress and changes in immune response via biomarker measures in women who develop a 
hypertensive disorder during pregnancy; 3) to review, summarize, and evaluate the 
literature examining the relationship between perceived maternal distress (stress, anxiety, 
and depression) and the development of a hypertensive disorder; and 4) to investigate the 
association of perceived distress in the development of a hypertensive disorder during 
pregnancy. 
Data obtained from a qualitative study of women with a hypertensive disorder 
during pregnancy placed on bed rest reported several stressors associated with the 
experience. These stressors related to differing and often conflicting management plans 
by different providers and not feeling providers heard their concerns. The evidence 
supports these women experience stress during this pregnancy complication. Analysis of 
data obtained at each trimester of pregnancy did identify differences in biomarker levels 
based on perceived stress and women with a hypertensive disorder and those without a 
hypertensive disorder. Evidence from a systematic review of literature supporting 
maternal distress in the development of a hypertensive disorder was mixed. However, 
few studies existed and of those reviewed, most lacked rigor. Analysis of data obtained 
early and late in pregnancy did not indicate a relationship between psychological distress 
and the development of a hypertensive disorder in pregnancy. Women with a higher BMI 
were 12% more likely to develop a hypertensive disorder. 
The factors associated with the development of a hypertensive disorder are 
complex. Maternal perceived stress and inflammatory responses differ between women 
with a hypertensive disorder and those without a hypertensive disorder in pregnancy; 
however maternal distress did not differ between groups. Body mass index was 
associated with the development of hypertension in pregnancy. Clinicians need to include 
assessment of maternal BMI as a modifiable risk factor in the development of a 
hypertensive disorder during pregnancy. In addition, although psychological distress was 
not associated with the development of a hypertensive disorder, women still suffer with 
components of distress. Clinicians could identify and support women experiencing 
distress thereby promoting a healthier pregnancy. 
KEYWORDS: Maternal Distress, Hypertensive Disorder in Pregnancy, Biomarkers 
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Chapter I: Introduction 
Background 
 Hypertensive disorders in pregnancy occur in 5-10% of all pregnancies in the 
United States (Kuklina, Ayala, & Callaghan, 2009). These disorders are one of the 
greatest causes of maternal and perinatal morbidity and mortality. In the United States, 
the rate of pregnancy-related mortality from hypertensive disorders was 7.6% in 2012 
(Centers for Disease Control and Prevention, 2016).  
Hypertensive disorders in pregnancy can be classified into four categories: 1) 
preeclampsia-eclampsia, 2) chronic hypertension, 3) chronic hypertension with 
superimposed preeclampsia, and 4) gestational or pregnancy-induced hypertension 
(American College of Obstetricians and Gynecologists, 2013). Preeclampsia is one of 
most serious form of hypertensive disorders during pregnancy. The rate of preeclampsia 
in the United States has increased 25% in the last two decades resulting in becoming the 
leading cause of maternal and infant illness and death (American College of Obstetricians 
and Gynecologists, 2017). 
Researchers have reported a maladaptive maternal inflammatory response may 
play a role in the development of a hypertensive disorder during pregnancy. A systemic 
inflammatory response is common to all pregnancies and changes throughout pregnancy; 
however, an increased pro-inflammatory response has been associated with the 
development of a hypertensive disorder (Moreli, Ruocco, Vernini, Rudge, & Calderon, 
2012; Palm, Axelsson, Wernroth, Larsson, & Basu, 2013; Szarka, Rigó, Lázár, Bekő, & 
Molvarec, 2010). Furthermore, maternal psychological distress (stress, anxiety, and 
depression) has been associated with this high-risk pregnancy and may influence 
maternal inflammatory response (Franco, Ferreira, Vieira, & Silva, 2015; Kurki, 
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Hiilesmaa, Raitasalo, Mattila, & Ylikorkala, 2000; Qiu, Williams, Calderon-Margalit, 
Cripe, & Sorensen, 2009; Yu et al., 2013; Zhang et al., 2013).  
The purposes of this dissertation were to: 1) explore the experience of having a 
hypertensive disorder during pregnancy; 2) to investigate the association of perceived 
stress and changes in immune response via biomarker measures in women who develop a 
hypertensive disorder during pregnancy; 3) to review, summarize, and evaluate the 
literature examining the relationship between perceived maternal distress (stress, anxiety, 
and depression) and the development of a hypertensive disorder; and 4) to investigate the 
association of perceived distress in the development of a hypertensive disorder during 
pregnancy. Four manuscripts, one addressing each purpose, are presented in Chapters 
Two through Five. 
Summary of Theoretical Framework 
 The first framework utilized was developed by Lazdam et al. in 2011. This 
framework illustrated maternal inflammatory response and its relationship to the 
symptoms of preeclampsia, which is primarily endothelial dysfunction (Lazdam et al., 
2011). The framework associated both maternal factors and systemic inflammatory 
response to endothelial dysfunction in addition to several other factors. However, the 
focus of this framework was the symptoms of preeclampsia and not preeclampsia itself or 
gestational hypertension so a more comprehensive model was needed that included other 
forms of hypertensive disorders.  
 The psychoneuroimmunology framework (PNI) is a more comprehensive model 
that illustrates associations between psychological distress, immunity or inflammatory 
responses, and pregnancy outcomes including hypertensive disorders of pregnancy 
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(Christian, 2012b; Coussons-Read, Okun, & Simms, 2003). The pathway of the 
psychological distress is by way of the sympathetic nervous system and activation of the 
hypothalamo-pituitary-adrenal axis thereby altering the inflammatory response leading to 
adverse pregnancy outcomes. The framework consists of environmental stressors 
moderated by coping resources and leading to psychological distress. Psychological 
distress may affect immune function directly or through health behaviors. In turn, 
immune responses or inflammatory responses may affect maternal health (hypertensive 
disorders). Within the PNI framework, the construct of psychological distress included 
perceived stress, general anxiety, and depressive symptoms. Furthermore, the concept of 
psychological distress is on a continuum with low stress at one end and anxiety or 
depression at the opposite end (Emmanuel & St John, 2010).  
This more comprehensive model provides a valuable framework for the 
explanation of how stressors and psychological distress can impact hypertensive 
disorders in pregnancy. In addition, it also allows for future interventional studies related 
to coping resources and health behaviors. 
Chapter Overviews 
 Overview of Chapter Two 
 
 Preeclampsia is a hypertensive disorder in pregnancy that can put a women and 
fetus at risk for adverse outcomes (American College of Obstetricians and Gynecologists, 
2013). Women with preeclampsia often experience both a physical and psychological 
hardship in these pregnancies (Malakouti, Sehhati, Mirghafourvand, & Nahangi, 2015). 
Psychological issues, including stress and anxiety are often exhibited in this population 
 4  
partly due to the management of this high-risk condition including prolonged bed rest 
(Rubarth, Schoening, Cosimano, & Sandhurst, 2012).  
Bed rest as a treatment modality for preeclampsia was first documented in the 
1950’s (Morris, Osborn, Wright, & Hart, 1957) and continues to be recommended as a 
treatment for the progression of preeclampsia. Researchers have reported up to 93% of 
maternal fetal medicine physicians and obstetricians have prescribed bed rest despite the 
latest recommendations from ACOG (American College of Obstetricians and 
Gynecologists, 2013; Bigelow & Stone, 2011).  
Although researchers have reported about the experience of preeclampsia women 
placed on bed rest, the psychological and emotional support these women may need has 
not been thoroughly documented. In addition, the author could not find any qualitative 
research related to preeclampsia and bed rest after the new 2013 ACOG guidelines were 
released. In Chapter Two, a qualitative descriptive approach provided a comprehensive 
summary of the experience of having preeclampsia and subsequently being placed on bed 
rest in 2015. As a result of this study, women experienced a variety of stressors most 
similar to ones women reported 20 years ago. Healthcare workers should take a more 
pro-active approach in assessing and addressing the psychological needs of these women. 
Future research should focus on stress reduction strategies for these women. 
Additionally, as healthcare delivery and management of preeclampsia continues to 
evolve, clinicians should incorporate evidence-based practices and communicate these 
practices to the women they treat thereby potentially reducing maternal stress and 
anxiety. 
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 Overview of Chapter Three 
 Hypertensive disorders in pregnancy are common complications occurring in five 
to ten percent of pregnancies in the United States (Kuklina et al., 2009). Although the 
exact mechanism underlying hypertensive disorders in pregnancy, there is evidence of the 
involvement of a maladaptive maternal inflammatory response (Eiland, Nzerue, & 
Faulkner, 2012; Palm et al., 2013; Ramma, 2011). Preeclampsia is associated with an 
overall pro-inflammatory response with elevated amounts of pro-inflammatory cytokines 
(Szarka et al., 2010). These serum biomarkers provide a quantifiable measure of the 
inflammatory response. 
 Perceived maternal stress experienced during pregnancy can increase the risk of 
preeclampsia (Zhang et al., 2013). Researchers proposed the hypothesis that maternal 
perceived stress during pregnancy has a negative effect on pregnancy outcomes by 
altering maternal inflammatory response (Coussons-Read, 2012). Elevated perceived 
stress was related to higher levels of biomarkers early and late in pregnancy (Coussons-
Read, Okun, & Nettles, 2007). However, most studies of maternal stress and the 
inflammatory response in the development of a hypertensive disorder are cross-sectional. 
In addition, biomarker measures are not consistent across studies and conclusions about 
their importance equivocal. Bridging the gap between maternal stress, inflammatory 
response and early detection of a risk of a hypertensive disorder could improve 
pregnancy outcomes in this population by identifying those women at an increased risk 
and allowing possible interventions to reduce the risk. 
 A secondary data analysis from a prospective non-experimental study of 
culturally and ethnically diverse women recruited from three prenatal clinics was 
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conducted (Ashford et al., 2015). In this investigation, a 1:2 cases control design was 
used. Cases were women diagnosed with a hypertensive disorder of pregnancy and 
controls were women without a hypertensive disorder matched on age and parity. Study 
measures were collected at each trimester of pregnancy. Systemic inflammation was 
measured with biomarkers, specifically both pro- and anti-inflammatory cytokines. Stress 
was measured through the Everyday Stressors Index (ESI) (Hall, 1983). Results of these 
analyses determined no significant differences in inflammatory biomarkers between 
hypertensive and normotensive groups in each trimester. When stress was dichotomized, 
there were differences inflammatory biomarker levels within these groups. The 
interaction of stress level, hypertensive status, and trimester was significant for one 
inflammatory biomarker, IL-10.  
Overview of Chapter Four 
Chapter four provides an investigation of the current literature related to the 
association between psychological distress and the development of a hypertensive 
disorder. Maternal psychological distress conditions including stress, anxiety, and 
depression has been associated with hypertensive disorders in part through maternal 
dysregulated inflammatory response (Vianna, Bauer, Dornfeld, & Chies, 2011).  
Prevalence of psychological distress in pregnancy has been reported between 13 
and 25% (Çapik & Pasinlioglu, 2015) with stress being reported most often. The March 
of Dimes indicated nearly 75% of women experienced at least one stressful event in the 
12 months prior to delivery (March of Dimes, 2015). Studies reflect this high rate in 
examining the components of distress by focusing primarily on maternal stress utilizing 
various operationalized definitions of stress. Studies focusing on depression or anxiety in 
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the development of a hypertensive disorder have received the least attention. 
Additionally, few studies have combined more than one component of psychological 
distress in the development of a hypertensive disorder. 
The author carried out a systematic review of the literature from 2001 to 2016 to 
examine the associations of at least two components of psychological distress with the 
development of a hypertensive disorder in pregnancy. Furthermore, the author first 
operationally defined the concepts of maternal stress, anxiety, and depression and utilized 
a conceptual framework to guide this review.  
Overview of Chapter Five 
Pregnancies are characterized by psychological and biological changes. 
Psychological changes are often activated through hormonal fluctuations (Rallis, 
Skouteris, McCabe, & Milgrom). However, sometimes these changes are maladaptive 
and can lead to adverse outcomes such as in the development of a hypertensive disorder 
(Vianna et al., 2011). Prevalence of psychological distress has been reported in up to 25% 
of pregnancies (Çapik & Pasinlioglu, 2015). Limited research and lack of consensus 
about the association of psychological distress with the development of a hypertensive 
disorder prohibits the understanding of this relationship. Existing research has lacked 
using theoretical frameworks, has not been comprehensive by including all the 
components of maternal psychological distress and has lacked the use of valid measures 
to assess psychological distress. Furthermore, existing studies primarily have been cross-
sectional and failed to capture changes in psychological distress over time. 
The author conducted a secondary data analysis using data collected from a 
prospective multicenter study (Hieronymus, Combs, Coleman, Ashford, & Wiggins). A 
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case-control study was conducted. The cases, women with a hypertensive disorder of 
pregnancy, were frequency matched on age and parity with normotensive pregnant 
women.  There were 29 women with hypertension and 87 without the disorder. Three 
hypotheses were tested using the PNI framework. In addition, valid self-report 
instruments evaluated maternal perceived stress as well as symptoms of depression and 
anxiety at two different time points during pregnancy. Results of this study did not 
support any differences in psychological distress between women with a hypertensive 
disorder of pregnancy and those without the disorder. Additionally, none of the 
psychological distress components, perceived stress, depressive symptoms, or symptoms 
of anxiety were independent predictors in the development of a hypertensive disorder. 
Body mass index was an independent predictor of this disorder.  
Overview of Chapter Six 
Chapter Six provides an overview of study findings and suggests 
recommendations for future research into the study variables of this dissertation as well 
as additional variables suggested by the comprehensive PNI framework. Further use of 
this framework is recommended to include interventional studies using coping strategies 
and modifying risk behaviors to reduce the psychological distress, inflammatory response 
and ultimately the adverse pregnancy outcome of a hypertensive disorder. 
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Chapter II: The Experience of Preeclampsia and Bed Rest: Mental Health 
Implications 
Background 
 Preeclampsia is a major cause of maternal and fetal morbidity and mortality that 
affects 5-10% of pregnant women globally, 3-5% in the United States (U.S. Department 
of Health and Human Services, 2013). Women with preeclampsia experience significant 
physical as well as psychological hardship (Malakouti et al., 2015). Mental health issues, 
including stress and anxiety are often exhibited in this vulnerable population partly due to 
the rigid management of this high-risk condition including prolonged bed rest (Rubarth et 
al., 2012). Preeclampsia has recently been defined as new onset hypertension (systolic 
blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg) and proteinuria 
(>300 mg/24 hr) after 20 weeks of gestation (Ramma, 2011).  In the absence of 
proteinuria, new-onset hypertension with any of the following:  thrombocytopenia 
(platelet count < 1000,000/microliter), impaired liver function, new development of renal 
insufficiency (elevated serum creatinine > 1.1 mg/dL), pulmonary edema, or new-onset 
cerebral or visual disturbances (American College of Obstetricians and Gynecologists, 
2013). This new expanded definition of preeclampsia adopted in 2013 by the American 
Congress of Obstetricians and Gynecologists (ACOG) has increased the number of 
diagnoses by 20% (Woelkers, Barton, von Dadelszen, & Sibai, 2015).  
Preeclampsia occurs primarily in first pregnancies and other risk factors include: 
chronic high blood pressure, chronic kidney disease, history of high blood pressure or 
preeclampsia in prior pregnancy, obesity, women younger than 20 years or older than 35 
years, being African American, or having a family history of preeclampsia (U.S. 
Department of Health and Human Services, 2013). Each year in the United States, more 
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than 204,000 hospitalizations occur due to preeclampsia (Barton, Istwan, Rhea, Collins, 
& Stanziano, 2006). Serious maternal complications of preeclampsia can include acute 
renal failure, acute liver injury, seizures, pulmonary edema, hemolysis, and 
thrombocytopenia (Ramma, 2011). Since delivery of the fetus and placenta is the only 
relief of the syndrome, and fetal complications can arise with a preterm birth, 
interventions are often directed at preserving the pregnancy until closer to term.  
Bed rest as a treatment modality for preeclampsia was first documented in the 
1950s (Morris et al., 1957). In this landmark study, Morris et al. examined the impact of 
bed rest on blood pressure by comparing women on bed rest with women on bed rest 
performed leg exercises. Morris used these leg exercises to increase blood pressure 
simulating the increased blood pressure experienced with preeclampsia. Morris 
postulated that even in normal pregnant women, exercise decreases the perfusion to the 
uterus and possibly mimics the preeclamptic patient’s circulation; thus suggesting a more 
profound decrease in uterine blood-flow in women experiencing preeclampsia (Morris et 
al., 1957). Because exercise diminishes circulation to vital organs it was thought that bed 
rest would improve circulation to these organs. This study was among the first to report 
that maternal bed rest reduced blood pressure and is thought to be the reason many 
healthcare providers began to recommend bed rest therapy for preeclampsia. 
Healthcare providers continued to recommend bed rest as a treatment for the progression 
of preeclampsia. Historically, the reported benefits of bed rest were thought to include the 
reduction of edema, improved fetal growth, prevention of progression to severe 
preeclampsia, and improved outcomes for the pregnancy (Sibai, 1996). In 2012, ACOG 
created a task force to update and educate healthcare workers about the definition, 
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diagnosis, and management of preeclampsia and pregnancy-induced hypertension. The 
ACOG report resulting from this task force states that bed rest is no longer recommended 
as a primary prevention of preeclampsia and its complications, nor is bed rest 
recommended for the treatment of preeclampsia in most women (American College of 
Obstetricians and Gynecologists, 2013). However, bed rest is still being used in this 
population, as evidenced by the fact that 89% to 93% of both maternal fetal medicine 
physicians and obstetricians utilize bed rest for a variety of indications and in a variety of 
restrictions (Bigelow & Stone, 2011). 
Data regarding the utility of holistic methods to address the mental health needs 
of high-risk mothers being placed on home or hospitalized bed rest is limited. In a 
randomized controlled trial (RCT) the efficacy of a single music session or recreation 
therapy intervention for hospitalized pregnant women effectively reduced antepartum-
related distress (Bauer, Victorson, Rosenbloom, Barocas, & Silver, 2010). Yet another 
RCT using a holistic music therapy intervention (30 minutes on 3 consecutive days) was 
found be effective in reducing anxiety levels and improving physiological responses of 
pregnant women placed on bed rest (Yang et al., 2009). Support groups have also been 
found to be an effective method to assist high-risk mothers in coping with bed rest both in 
the hospital and at home (Adler & Zarchin, 2002; Maloni & Kutil, 2000). Maloni and 
Kutil reported an unstructured support group that provides hospitalized women on bed 
rest with an opportunity to voice their concerns in a supportive environment may be an 
important nursing intervention in helping these women cope (Maloni & Kutil, 2000). In 
the event women cannot be together physically, a virtual support group using the internet 
to reach women with high-risk pregnancies on home bed rest was shown to be effective. 
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Adler and Aarchin stated that women reported participating in the virtual focus group 
was valuable and beneficial in helping them cope with the difficulties of bed rest (Adler 
& Zarchin, 2002). 
Preeclampsia is a serious condition with the potential for adverse outcomes, and 
although some investigators have described the perceptions, beliefs and emotional 
experiences of pregnant women with high-risk pregnancies who are placed on bed rest, 
fewer have researched preeclampsia, specifically or have revisited this topic since the 
2013 release of the new ACOG guidelines. The psychological and emotional support 
these women may need has not been thoroughly documented and, holistic interventions 
have not been utilized to their potential. In order for clinicians to provide adequate 
psychosocial support to these women, it is important for us to gain a better understanding 
of the lived experience that women with preeclampsia have on bed rest and the 
effectiveness of the holistic interventions provided to these women. 
Therefore, the primary aim of the study was to describe women’s experience of 
having preeclampsia and being placed on extended bed rest during their pregnancy 
despite the newest recommendations from ACOG and bed rest for treatment of 
preeclampsia. Secondary aims included: 1. identifying key stressors that women 
experience while on bed rest, and 2. identifying healthcare provider management of 
maternal stress related to prolonged bed rest. 
A qualitative descriptive approach provided a comprehensive summary of the 
experience of being placed on bed rest. According to Sandelowski (2000), qualitative 
description allows for ‘low-inference’ interpretation of the data that is likely to result in 
consensus among researchers.  The primary component of qualitative descriptive 
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methodology entails using everyday language to describe participant’s personal accounts 
providing a comprehensive summary of a specific phenomenon (Sandelowski, 2000).  In 
qualitative description, data trustworthiness is established through the credibility, 
confirmability, transferability and dependability of the data. 
Design and Method 
Qualitative description was used to provide a comprehensive summary of the 
experience of being placed on extended bed rest and/or hospitalization for preeclampsia. 
ATLAS.ti 6.2 software was used to analyze the data. This software allows for analysis of 
qualitative data including interviews.  
Recruitment and Sample 
The study was approved by the Institutional Review Board at the University of 
Kentucky. In order to participate in the study, women had to meet these inclusion criteria: 
18-45 years old, able to communicate in English, and have a current diagnosis or history 
of preeclampsia per self-report in the past ten years in which they were placed on some 
form of bed rest (home or hospital) for at least 7 days. Study participants were recruited 
through Facebook postings from Evidence Based Birth, a pregnancy and childbirth blog 
with more than 20,000 Facebook followers. After potential participants contacted the 
principal investigator, they were screened for eligibility and provided an email with a 
cover letter and link to Survey Monkey for informed consent. The minimum of a 7 day 
bed rest period was chosen based on previous selection criterion in studies completed by 
Gupton and Richter (Gupton, Heaman, & Ashcroft, 1997; Richter, Parkes, & Chaw-Kant, 
2007). Women were excluded if they did not have access to a phone or computer. 
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In a four month time period, twenty women initially responded to the Facebook postings.  
Of the twenty women, seven women met inclusion criteria and completed the study. The 
remaining 13 women either did not meet inclusion criteria and/or choose to not enroll due 
to time constraints.   
Data Collection 
Following consent, the PI and participant established an interview date and time. 
Data were collected via a one-on-one recorded phone interview. Study participants were 
asked open-ended questions in an individual interview that took place over the phone. 
Guided questions were used to conduct the interview allowing for the participants to 
expand in any direction they chose. In addition to guided questions, a few perinatal 
questions such as gestational age at diagnosis, how bed rest was defined, how long ago 
since diagnosis and treatment, as well as some demographic information including: age, 
race, occupation, marital status, and number of children were obtained. See Appendix for 
interview questions. On average, the interviews lasted one hour, with a range of 37 
minutes to 1 hour and 11 minutes. The activities of the PI and interview process were 
reviewed by two of the authors to demonstrate dependability with the research methods. 
Data Analysis 
Participants were de-identified and referred to as A, B, and C, etc. The recordings 
were professionally transcribed verbatim, and checked for accuracy. Following the design 
of Rubarth, et al (2012), transcriptions were read several times by the PI to achieve a 
basic understanding of the information and summarized. Three of the team members 
reviewed the transcripts and identified patterns. Once transcribed and verified, all voice 
recordings were deleted. Content analysis was used to analyze the data. The patterns 
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identified were coded and grouped into themes by three of the authors to decrease 
researcher bias and demonstrate confirmability reliability with the data. Codes were 
attached to the transcript to identify themes using ATLAS.ti 6.2. These were kept in a 
code book as a separate file. All meanings and themes were traceable back to the 
individual transcription to enhance credibility. The study of seven women with similar 
demographics did provide some level of richness for this group of women. This rich 
description of the experience of having preeclampsia and being placed on bed rest 
demonstrates transferability. 
Results 
 The women of this study were all Caucasian with a mean age of just over 30 years 
old. They were all college educated, married, and employed full-time at the time of 
diagnosis. Two women were gravida 2, and the others were gravida 1. The length of bed 
rest was between 2 and 9 weeks for these women, and their gestational ages were 
between 29 and 37 weeks. See Appendix A for more demographic information and a bed 
rest timetable about the sample. 
 During data analysis, six themes emerged in which women described stressors 
that they experienced. These stressors included negative feelings and thoughts, lack of 
guidelines and/or knowledge about their diagnosis, lack of social support, not being 
heard, loss of normal pregnancy, and physical symptoms. 
Negative feelings and thoughts 
All of the participants described having negative feelings and thoughts related to 
their experience of preeclampsia and being placed on bed rest. Some of these negative 
feelings could be characterized as anxiety related symptoms. The participants used terms 
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like “nervous wreck,” “major meltdown,” “stressed out,” and “scared” to describe their 
mood. One participant recalled having this anxious thought after she “Googled” 
preeclampsia: 
 “I saw what could go wrong and then it was like, ‘Oh my gosh, I’m going to die 
and my baby is going to die,’ and it all started spiraling out of control.”  
And another woman stated: 
 “Every time I went to the doctor I had this like near anxiety attack.” 
Women shared the negative thoughts that occurred to them while they were on bed rest: 
 “To me it felt like I was just sitting on bed rest, waiting to have a seizure, you 
know, waiting to completely start circling the drain.” 
Some women experienced more depression-like symptoms of “mental funk” and 
used words like “sad and frustrated” to describe how they felt. One woman talked about a 
friend who committed suicide shortly after having a complicated pregnancy and delivery. 
She expressed concern and empathy toward her friend saying: 
 “I just sometimes wonder and I can almost feel where it would be easy to fall into 
that because you have all these negative feelings anyway.” 
Another woman shared: 
 “I was a wreck. I probably cried every day.” 
 In addition to anxiety and depressive symptoms, five of the seven women revealed 
fearful thoughts they had about their unborn child: 
 “It was a very strong mental feeling of something is not right and this pregnancy 
needs to end…I felt an impending doom…I felt like I was being poisoned, like the baby 
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in my body was killing me slowly.” Another woman stated, “When you start reading 
about growth restriction, it’s very scary.” 
Finally, women mentioned experiencing negative thoughts about failure, guilt, 
and loss. Four of the seven women described these types of negative thoughts about their 
bodies and pregnancies.  One woman noted: 
“I feel like a failure. I feel like I am flunking, you know, like this is my fault.  
That’s how I felt about these blood pressures.” 
And another stated: 
“My caregivers from the beginning were telling me to make sure you’re 
exercising, make sure you are eating a certain way and it will help to make sure you don’t 
get complications…I was kind of mad because I was following the recommendations and 
they didn’t work. I felt like I did all of this for nothing.” 
Still another commented: 
“I wanted to be pregnant. I’m not really ill, I should be stronger and I should be 
handling this better.” 
Lack of guidelines 
Frustration was a common feeling from four of the seven women when dealing 
with their healthcare providers throughout their complicated pregnancies. These women 
often received conflicting information or “mixed messages” from various providers of a 
group, or did not receive any information pertaining to their diagnoses. Often not having 
continuity of care led to miscommunications or inconsistent information being provided 
to these women. Only two of the seven women could positively identify a standard 
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protocol for preeclampsia being used during their pregnancies. One woman was 
especially frustrated with her providers stating: 
 “I would go in and say I need to have a non-stress test and it was never on the 
schedule.  One doctor wants me there twice a week, then I end up seeing his partner and 
he says I don’t need to come twice a week but only once a week. Then I get stuck with 
the other doctor and he asks why did I not come in twice a week for my stress test?”  
 The same woman goes on to say: 
 “I went in to the office because I gained 7 pounds in 3 days and my blood 
pressure is teetering over that 140/90 range so I expected to be induced…a different 
doctor sees me and she says I’m fine and not even preeclamptic…Don’t come back 
unless you are consistently 140/90” 
 Another woman tells the story of how she was induced stating: 
 “I went in for my non-stress test, my blood pressure was 150/110 and the midwife 
said, we’ll keep that plan of not inducing for another five days and then went out, talked 
to the OB, and came back in and said, no, we’re inducing you right now.” 
 Some women experienced a feeling of having a general lack of information about 
their diagnosis. Four of the seven women mentioned that they specifically wanted their 
care providers to use evidence-based medicine, but they were not provided with 
information about the evidence behind their care, and they sometimes doubted the 
information given to them by their providers.  One woman is still doubtful that she had 
preeclampsia at all during her pregnancy.  She states: 
 (Her provider tells her) “You know you’re developing preeclampsia. I said oh 
really, how do you know? He said your uric acid is five…and it should go down at the 
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end of pregnancy.  I knew this isn’t true and I made it my mission to find out what the 
normal levels of uric acid at the end of pregnancy and sure enough, it goes up until you 
deliver.” 
 And 
 “I tried to do everything they (the perinatology office) said to do, which was to 
stop exercising and bed rest and all of that stuff, even though at the back of my mind I 
pulled up the ACOG recommendations that said no one should be on bed rest anymore.” 
Lack of social support 
All seven of these women expressed a need for increased social support during 
this time of their pregnancy. They used words like “need” and “would have helped.” One 
woman mentions how she tried to reach out to her church but they couldn’t see her need. 
She states: 
 “My preacher is a women and I texted her and told her I was on bed rest. I was 
shocked that they weren’t asking if they could send someone over with a meal or 
whatever. Not to judge my church, I was just kind of shocked by that because I feel like if 
someone is older or something, everyone jumps to help them.” 
 Three of the women did not feel support from their health care providers. One 
woman did not feel she had any sort of relationship with her providers, and another felt 
she could not call her provider’s office with questions or concerns.  The third woman 
described an unsupportive encounter at her provider’s office: 
 “At the perinatology office, the nurse that checked me in said, like she made this 
horrible face one day and said ‘oh, that blood pressure is just terrible’.  Those were her 
exact words.” 
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 These women often relied on their spouses and family for support, but they 
worried about the stress placed on their families as well. Some of these women noticed 
the toll their condition was taking on their spouses and family members. Four of the 
seven women mentioned the added stress they noticed particularly in their spouses. They 
mentioned “hard”, or “extremely stressful”, or “absolutely stressed” when describing the 
impact their situation was having on their husbands.  One woman states: 
 “He knew I was sick and he knew I was not feeling well.  I think that just scared 
him in general because he’s a worry wart about health-type things.” 
 Another woman mentions: 
 “I think that he did his best to not (be stressed).  He’s king of an easygoing guy 
and I think he did his best to be optimistic about it, but it was definitely stressful for 
him.” 
Not being heard 
One of the most common stressors, identified by six of the seven women in this 
study, was a feeling of not being heard by their providers. All of these women had 
college educations and tried to communicate with their providers, but they felt that their 
questions were not answered and their concerns were not addressed. They used phrases 
like “blown off”, “no consideration”, “brushed off”, and “write everything off” when 
discussing how they felt when they addressed concerns they had with their providers. A 
woman tells of her provider’s response to her questions stating: 
 “When I had questions, she would just say oh that’s normal, everyone does that, 
without even answering the question. Even to the point where I suggested that we don’t 
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try medicine first. She just kind of laughed at me and said, you let me know how that 
goes.” 
 Yet another woman explained that she felt her providers thought she was a 
hypochondriac. 
 “Some of them just want to blow me off and like: This girl is crazy. She comes in 
and brings her blood pressure and says she needs a non-stress test and all this stuff.” 
 One woman went as far as bringing in proof of her physical symptoms to try to 
gain some attention from her providers saying: 
 “I started to feel really bad and I started to feel like there was going to be a 
problem and every time I brought this up, you know I even took pictures of my legs at the 
end of the day and I showed it to them and it was just like, oh every pregnant woman 
swells, and gets short of breath.” 
Loss of normal pregnancy 
Four of the seven women discussed what they perceived as a loss. Each of these 
women had an idea in their head about their pregnancies and struggled to manage their 
feelings when their pregnancies no longer “fit” their idea of normal. One women had 
developed a birth plan and found out that: 
 “You have what your actual pregnancy is, which is none of the ways you 
anticipate planning.” 
 Another woman described her birth plan as a picture stating: 
 “It’s very hard to take that picture you have and repaint it.” 
 One woman describes the transition of a normal pregnancy to one with 
preeclampsia as this: 
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 “It went from totally healthy and normal and we’re going to have a baby to not 
feeling healthy and seeing that my body didn’t like being pregnant.” 
Physical symptoms 
The most common physical symptom of these women was fatigue.  The women 
used words like “tired”, “exhaustion”, and “lack of ambition”. One woman mentioned: 
 “Even if I wasn’t sleeping, I found that I didn’t have a lot of energy doing things.” 
 One woman recalls her swelling being so bad that it caused “a lot of carpal 
tunnel” and her husband had to “lift up her foot high enough to put on underwear.”   
 Another woman describes and overall feeling of sickness or flu-ish stating: 
 “I guess you know that kind of punky, headachy, nothing quite feels right 
(feeling)”. 
Discussion 
There is limited research regarding the experience of women on bed rest for the 
prevention or treatment of preeclampsia specifically, rather they focused on bed-rest for 
high-risk pregnancies in general. Some studies reported on the experience of bed rest 
either at home or in the hospital. Women with preeclampsia may already be experiencing 
increased anxiety, fear, and stress, which could be aggravated by early maternal bed rest 
or hospitalization prior to delivery (Souza et al., 2007). Schroeder reported that women 
with a high-risk pregnancy, such as preeclampsia, described a high level of physical, 
emotional, familial, and economic hardship when placed on bed rest (Schroeder, 1996). 
Gupton et al. also examined high-risk pregnant women on bed rest and determined these 
women identified stressors, including lack of control, assuming a sick role, concerns for 
fetus, missing out, and boredom (Gupton et al., 1997). May described women’s stressors 
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as manageable if they could balance the needs of family with activity restriction, but 
those that could not find balance experienced uncomfortable levels of emotional distress 
(May, 2001). Leichtentritt, et al., described the experience of hospitalized women with 
high-risk pregnancies as having an essential theme of ambivalence, that is to say, they 
feel anxious about the situation, but hopeful of the outcome; they feel emotionally “in” 
but physically “out” of their houses (Leichtentritt, Blumenthal, Elyassi, & Rotmensch, 
2005). Richter, et al., also reported on high-risk hospitalized women having stressors 
related to feelings of loss of control and being a burden (Richter et al., 2007).  Rubarth, et 
al., described women hospitalized with high-risk pregnancies as experiencing a “war 
within” as they battled an emotional roller coaster and feelings of imprisonment (Rubarth 
et al., 2012).  
The primary aim of this study was to describe the experiences these women have 
with preeclampsia and subsequent bed rest. Almost 20 years later, the experiences of 
these women are similar to those from the past, including this core set of feelings 
associated with a high-risk pregnancy such as preeclampsia and being placed on bed rest. 
One secondary aim included identifying the stressors these women experience. Many 
stressors are associated with having a diagnosis of preeclampsia and subsequently being 
placed on bed rest. The three primary stressors for these women included negative 
feelings including symptoms of anxiety and depression, frustration with the lack of 
evidence-based practices from health care professionals, and a feeling of not being heard 
by the health care professionals.  
The women of this study were frustrated with the apparent lack of evidence-based 
guidelines being used by their providers. Complete bed rest has been questioned since the 
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early 90’s due to the potential complications of maternal orthostatic hypotension, 
depression, venous thromboembolism, muscle atrophy, and bone demineralization 
(Schroeder, 1996). In addition, there is a psychological toll many women experience 
while placed on bed rest. Some researchers have stated that is not only complete bed rest 
a non-evidence-based practice, but that it is also an unethical treatment for pregnancy 
(McCall, Grimes, & Lyerly, 2013). In the 2013 report from the American College of 
Obstetricians and Gynecologists, experts suggested that bed rest or the restriction of other 
physical activity should not be prescribed for women with preeclampsia without severe 
features (American College of Obstetricians and Gynecologists, 2013). Additionally, bed 
rest is not defined the same within the maternal-fetal health community. All seven of the 
women in this study were given different definitions of bed rest and what bed rest 
entailed. Some women were told modified meant being in a bed or recliner unless using 
the bathroom while for others, it meant no exercise or work, or some activity for an hour 
or so occasionally. Nonetheless, varied types of bed rest are commonly prescribed for 
women with preeclampsia regardless of the severity.  
In our study, four of seven women were actively educating themselves about 
preeclampsia, the risks involved, and the treatments recommended or not recommended. 
These women wanted to be actively participating and engaged in their own care. Our 
finding is similar to research reported by Harrison et al, who found that most women 
wanted to be active participants in the decision making process around their care. Active 
participation was defined as having access to information about choices, and partnering 
with your healthcare provider to make decisions about pregnancy (Harrison, Kushner, 
Benzies, Rempel, & Kimak, 2003). One woman in our study had accessed the ACOG 
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guidelines and knew that bed rest was no longer recommended, and yet her provider 
placed her on bed rest anyways. She did not feel she could say anything to her provider 
about the contradiction, and she felt conflicted and frustrated with her provider. In the 
Harrison et al. study, women reported being dissatisfied when they felt left out of 
decision making, and were unable to ask for clarification of what was heard discussed 
about their care among their providers (Harrison et al., 2003).  
Today, women have more on-line access to information regarding treatment 
options for preeclampsia.  Most women obtain at least some portion of prenatal health 
information through the internet (Huberty, Dinkel, Beets, & Coleman, 2013; Lagan, 
Sinclair, & George Kernohan, 2010). Providers should be aware that many women are 
taking an active role by seeking out information regarding their pregnancies. By talking 
with women about what information they are reading online about their condition, this 
could reduce the frustration experienced by these women.   
Furthermore, their feelings are still not being addressed effectively by the 
healthcare system. The women included in this study experienced the same feelings and 
many also stated these feelings were not addressed by their providers. Another secondary 
aim was to learn what approaches providers used to address the stressors these women 
experience. Overall participants felt that their feelings were not addressed rather 
dismissed by their providers as six of the seven described feelings of being “blown-off” 
or “brushed-off”.  They felt that many of their questions went unanswered. Other studies 
have shown similar findings. In a study by East, et al., 19% of the women felt that 
doctors and midwives did not believe the mother was unwell when their preeclampsia 
became more severe (East, Conway, Pollock, Frawley, & Brennecke, 2011). The feeling 
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of not being heard affects how women view their prenatal care. Six of the women of this 
study did not reflect a positive relationship with their providers when they were not 
listened to or perceived as an over-concerned client. Women weigh certain characteristics 
in satisfactory prenatal care, one of which is questions to be asked and questions be 
answered along with understanding their personal experiences (Harrison et al., 2003). 
The fact that women in our study felt dismissed or not heard by their providers could 
raise serious safety issues as well, because the women might not be heard—or may be 
less likely to speak up—if they experience severe symptoms or warning signs related to 
their preeclampsia.  
Six of seven women explained how their providers never asked them how they 
felt throughout their high-risk pregnancies or what their feelings were about being placed 
on bed rest. When the women were asked how they would have responded if their 
providers had asked about their psychological well being, they claimed they would have 
been open and honest. Not surprisingly, these women wanted their providers to address 
their concerns. Results from a study by Harrison et al. support our findings, as women in 
their study reported that they wanted to be asked questions (from their providers) about 
their medical and emotional status (Harrison et al., 2003).  
Clinical and Nursing Implications 
 The stressors perceived by the women of this study are similar to those reported in 
previous research conducted nearly 20 years ago. These women reported significant 
mental health issues such as stress, anxiety and frustration. These feelings may be 
initiated or exacerbated by several factors such as having a high-risk pregnancy, knowing 
that evidence-based practices are not being utilized, and feeling they are not heard by 
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their providers. Although the women in this study were all Caucasian living in the United 
States, the recommendations from this study could be applied to women around the 
world. Screening women for psychological stress and offering holistic options to help 
manage stress could lead to healthier pregnancies for these women. During a pregnancy, 
women encounter a variety of healthcare professionals including nurses, doctors, and 
midwives. Any of them could address some of these factors by first exploring the feelings 
that women are experiencing with their high-risk pregnancy. Often nurses are the first 
responders when these women have complaints or concerns.  Nurses could utilize that 
contact to explore the needs of these women. Tools such as the Everyday Stressors Index 
(ESI) (Hall, Williams, & Greenberg, 1985) and Generalized Anxiety Tool (GAD-7) 
(Spitzer, Kroenke, Williams, & Löwe, 2006) can provide a measure of the perceived 
stress and anxiety these women are experiencing. Exploring what type of involvement 
each client is comfortable with, whether active or passive, and partnering with the client 
in decision-making, could offer the client a more satisfactory experience.  Health care 
professionals should talk with their clients about evidence-based practices, and directly 
ask and encourage open communication with their clients about what they know about 
their high-risk pregnancy. These techniques may help alleviate misinformation or 
confusion on the part of the client. Finally, health care professionals should adopt a more 
holistic and individualized approach to manage women experiencing preeclampsia.  Such 
an approach should incorporate a psychosocial wellness screening to assess for 
knowledge about the disease while carefully listening to individualized concerns. 
Techniques such as music therapy and focus groups, both in person and on-line, have 
promising results in helping women cope with the stressors of being placed on bed rest 
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with a high-risk pregnancy (Adler & Zarchin, 2002; Bauer et al., 2010; Maloni & Kutil, 
2000; Yang et al., 2009).  
Implications for Future Research 
Future research should focus on stress reduction strategies specific to women 
experiencing prolonged bed rest due to preeclampsia. Over the past two decades, the 
primary stressors associated with preeclampsia and bed rest (anxiety and frustration) have 
not changed (Schroeder, 1996). Interventional research focused on improving 
psychosocial wellness during this critical time period is warranted. Further, as healthcare 
delivery and management of high-risk pregnancy continues to evolve, future studies 
should be directed at implementation and evaluation of novel evidence-based practices, 
with particular focus on how these practices are communicated to the client. Improved 
communication, including teach-back methodologies, may provide to be beneficial in 
reducing maternal stress and anxiety while on prolonged bed rest. 
Study Limitations 
 This study utilized qualitative methods, and there was a lack of demographic 
differences; thus data are not generalizable. Further, women for this study were 
purposively chosen through the Evidence Based Birth® website; thus indicating a 
potential selection bias as these women were actively seeking information to educate 
themselves. However, this could also be described as strength, as the authors were able to 
take an in-depth look at the experience of women with preeclampsia on bed rest who 
wanted to be active participants in their care, and are motivated to learn about evidence-
based practices for preeclampsia. Although there were only seven participants, the in-
depth qualitative interviews allowed for a rich description of having preeclampsia and 
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experiencing prolonged bed rest. Future research should include expanded recruitment 
(non-online) to ensure a more diverse sample. The data was collected through self-
reporting of these women, including a diagnosis of preeclampsia. This can be considered 
a weakness, but these were their stories. The authors recognize that recounted 
experiences are filtered through the interviewee’s memory and in one case that memory 
was 10 years ago, but these women recounted their stories in great, colorful detail that the 
authors tried to capture 
Conclusions 
This study provides researchers and health care workers with a current viewpoint 
of the experience of women with preeclampsia placed on bed rest, and hopefully will lead 
to a better understanding of their needs. Preeclampsia and bed rest are associated with 
persistent stressors, including frustration, depression, and anxiety, that are often 
overlooked by health care providers. Further, women report increased stress when 
providers’ practices and recommendations conflict with evidence-based practices, and 
feelings of being dismissed by their providers during the course of their high-risk 
pregnancy. Care for these women can be improved if health care providers assess and 
manage psychosocial wellness, consistently follow evidence-based practices, and ensure 
time for effective communication and mutual exchange of information.  
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Chapter III: The Association of Maternal Stress and Immune Response with 
Development of a Hypertensive Disorder 
 
Introduction and Purpose 
Hypertensive disorders in pregnancy are common complications occurring in 5-
10% of all pregnancies in the United States (Kuklina et al., 2009). This high risk 
complication is associated with increased maternal and fetal morbidity and mortality, and 
is a risk factor for the development of maternal cardiovascular disease later in life (Eiland 
et al., 2012). In the United States, the rate of pregnancy-related mortality from 
hypertensive disorders in 2012 was 7.6% (Centers for Disease Control and Prevention, 
2016). Preeclampsia is the most prevalent hypertensive disease of pregnancy 
(Pennington, Schlitt, Jackson, Schulz, & Schust, 2012), with 17% of patients with 
gestational hypertension developing preeclampsia (Lo, Mission, & Caughey, 2013). 
Although the exact mechanisms underlying preeclampsia remain unclear, there is 
evidence of the involvement of a maladaptive maternal inflammatory response. Systemic 
inflammation is common to all pregnancies but it has been proposed that preeclampsia 
results from an imbalance in this response (Ramma, 2011). Researchers have 
demonstrated an association between inflammation and the endothelial dysfunction 
linked with preeclampsia, more specifically an increased pro-inflammatory response. 
Figure 3.1 is a theoretical framework developed by Lazdam et al. in 2011 illustrating the 
inflammatory response and its relationship to endothelial dysfunction (Lazdam et al., 
2011). 
One of the factors that may adversely influence the inflammatory response is 
maternal perceived stress. Psychological stress may increase the risk for preeclampsia by 
increasing activation of the maternal inflammatory system (Christian, 2012b; Coussons-
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Read et al., 2003; Crosson, 2012; Zhang et al., 2013). Limited data exist measuring these 
phenomena at each trimester during pregnancy. Substantial changes occur in maternal 
immune function over the course of a pregnancy; therefore, understanding the 
inflammatory process over each trimester would be beneficial (Christian, 2012b). The 
purpose of this study was to explore the association of maternal stress and inflammatory 
response with development of preeclampsia or other hypertensive disorder during 
pregnancy. The author tested the following specific aims: 1) determine differences in 
serum cytokine levels (IL-1α, IL-1β, IL-6, IL-8, IL-10, and TNFα) at each trimester of 
pregnancy based on maternal perceived stress (Everyday Stressor Index) categorized as 
high or low in women who do and do not develop a hypertensive disorder; 2) To 
determine the differences in serum cytokine levels over each trimester between 
stress scores (high or low) and a hypertensive disorder (hypertensive or 
normotensive). 
Background 
Preeclampsia is a severe complication of pregnancy affecting 5-10% of pregnant 
women globally and 3-5% in the United States (U.S. Department of Health and Human 
Services) (Ananth, Keyes, & Wapner, 2013; Lo et al., 2013). From 1980 to 2010, the 
prevalence of all cases of preeclampsia in the U.S. increased from 3.4% to 3.8%; 
however, the rate of severe preeclampsia increased by more than three-fold during this 
time from 0.3% to 1.4% (Ananth et al., 2013). Preeclampsia is one of the primary causes 
of maternal morbidity and mortality. Globally 50,000 women die each year from 
preeclampsia (Duley, 2009). Maternal morbidity associated with severe preeclampsia 
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includes acute renal failure, acute liver injury, seizures, pulmonary edema, hemolysis, 
and thrombocytopenia (Ramma, 2011).  
In addition, preeclampsia is a major cause of fetal mortality and morbidity. 
Researchers reported a stillbirth rate from 9 in 1000 to as much as 21 in 1000 related to 
mild and severe preeclampsia respectively (Simpson, 2002). Fetal morbidity associated 
with preeclampsia is also related to preterm birth, intrauterine growth restriction, fetal 
weight, and Apgar scores (Can et al., 2011; Mihu, Razvan, Malutan, & Mihaela, 2015).  
Hypertension during pregnancy is categorized as chronic hypertension, 
gestational hypertension, preeclampsia (including mild, superimposed, and severe forms), 
and eclampsia. Preeclampsia is defined as the new onset of hypertension (systolic blood 
pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg) and proteinuria (≥ 300 
mg/24 h) after 20 weeks of gestation. Severe preeclampsia is defined by systolic blood 
pressure ≥ 160 mmHg or diastolic blood pressure ≥ 110 mmHg and proteinuria                
≥ 2 g/24 h (American College of Obstetricians and Gynecologists, 2013). In the absence 
of proteinuria, preeclampsia can be diagnosed as hypertension in association with 
thrombocytopenia, impaired liver function, renal insufficiency, pulmonary edema, or new 
visual disturbances (American College of Obstetricians and Gynecologists, 2013). 
Preeclampsia can be categorized as early onset (< 34 weeks gestation), and late onset (> 
34 weeks gestation) (Eastabrook, Brown, & Sargent, 2011).   
The severity of the disease, gestational age at time of disease onset, and the 
existence of comorbidities affect the pregnancy outcomes. Women who develop the 
disease after 36 weeks gestation are less likely to experience adverse outcomes than 
women who develop the disorder before 33 weeks gestation primarily due to longer 
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gestation (Sibai, Gus; Kupferminc, Michael, 2005). For example, both gestational age 
(39.1 weeks) and birth weight at delivery (3217 grams) are higher in pregnancies with a 
preeclampsia diagnosis after 36 weeks (Sibai, Gus; Kupferminc, Michael, 2005). 
Additionally, rate of fetal death was approximately six times higher (AOR, 5.8; 95% CI, 
4.0-8.3) among women with early onset of the disease (Lisonkova & Joseph, 2013). 
Preeclampsia can also have long-term maternal effects. A history of preeclampsia 
is associated with doubling the maternal risk factor for developing cardiac, 
cerebrovascular, and peripheral vascular disease compared to women without this risk 
factor (Eiland et al., 2012; Giguère et al., 2012; Gilbert et al., 2008). In addition, women 
with a history of preeclampsia have a 3-5 fold increased prevalence of developing 
metabolic syndrome later in life (Giguère et al., 2012). 
 Normal pregnancy results in changes in maternal physiology including changes in 
host response. A shift toward an anti-inflammatory response and inhibition of a pro-
inflammatory response is associated in normal pregnancy (Ramma, 2011). Pro-
inflammatory markers include tumor necrosis factor alpha, interleukins -1α, -1β, -2, -6,    
-8, and -12. Anti-inflammatory marker includes interleukin-10 (Moreli et al., 2012; 
Ramma, 2011). Preeclampsia is hypothesized to be due to a maladaptive maternal 
immune response to pregnancy, specifically exaggerated inflammation (Eiland et al., 
2012; Palm et al., 2013; Ramma, 2011).  
Preeclampsia is associated with an overall pro-inflammatory systemic 
environment with elevated amounts of pro-inflammatory cytokines (Szarka et al., 2010). 
Tumor necrosis factor alpha (TNFα) increased in the second and third trimesters in 
women with preeclampsia (Moreli et al., 2012; Palm et al., 2013; Szarka et al., 2010). 
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Cytokines interleukins IL-6 and IL-8 increased, while IL-10 decreased when measured in 
the third trimester or at diagnosis (Borekci, Aksoy, Al, Demircan, & Kadanali, 2007; 
Kronborg et al., 2011; Szarka et al., 2010). Serum biomarker levels provide quantifiable 
measures of this inflammatory response; however, few studies were longitudinal in 
design. Exploring these changes throughout pregnancy, and prior to the development of 
preeclampsia holds promise in early identification and intervention for at-risk women. 
 Heightened, perceived maternal stress experienced during pregnancy can increase 
the risk for preeclampsia. Physiological responses occur in the body when exposed to 
stress (Crosson, 2012). These responses include the release of various inflammatory 
markers (Coussons-Read et al., 2007) and stress hormones such as cortisol (Crosson, 
2012). Coussons-Read et al. proposed the hypothesis that maternal perceived stress 
during the prenatal period has a negative effect on pregnancy outcomes by altering the 
maternal immune response (Coussons-Read et al., 2003).  Perceived stress in the 
mother’s life during pregnancy was associated with an increased risk (odds ratio (OR), 
1.7%; 95% CI, 1.3-2.2) of preeclampsia (Yu et al., 2013). Women with perceived stress 
were more than twice as likely to develop preeclampsia during their pregnancy (OR, 2.1; 
95% CI, 1.5-2.8; p<0.001) (Zhang et al., 2013). Elevated maternal perceived stress was 
also related to higher levels of IL-6 early and late in pregnancy, and lower levels of IL-10 
early in pregnancy (Coussons-Read et al., 2007). Unfortunately, biomarker measures are 
not consistent across studies and the conclusions about their importance equivocal.  
 There are limited data about maternal stress and inflammatory response measured 
at each trimester, and the association with the development of preeclampsia. Determining 
maternal stress levels in conjunction with measurement of trimester-specific immune 
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markers may assist practitioners in identifying women at risk for the development of 
preeclampsia. Given the relationship between trimester-specific maternal stress and 
inflammatory response is established, early detection of preeclampsia may be possible; 
thus increasing likelihood of improved pregnancy outcomes.  
Design and Method 
The current investigation was a secondary analysis of a longitudinal, repeated 
measures, multicenter study of culturally and ethnically diverse pregnant women 
(Ashford et al., 2015). The primary aim of the parent study was to determine if trimester-
specific prenatal inflammatory markers linked with psychosocial and biobehavioral 
variables pose a significant risk for preterm birth. The parent study was conducted at the 
University of Kentucky College of Nursing from 2010-2014 and was approved by the 
University of Kentucky’s Institutional Review Board (IRB). In the current study, a 1:2 
case control design from data collected in the parent study was used. Participants were 
matched on age and parity. Cases consisted of women diagnosed with a hypertensive 
disorder of pregnancy, while controls consisted of women without a hypertensive 
disorder.  
Sample  
The inclusion criteria for the parent study were pregnant women older than 16 
years of age with a singleton gestation. The exclusion criteria for the parent study were 
history of Type 1 or Type 2 diabetes, history of any heart disease, current history of 
illegal or prescription drug abuse via urine drug screen, diagnosis of bacterial vaginosis 
or sexually transmitted disease, any autoimmune disease, and multifetal pregnancies. 
Women with chronic disease and/or multifetal pregnancy were excluded due to their 
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significant association with preterm birth (Institute of Medicine, 2006). Other exclusion 
criteria were based on factors that would alter the maternal immune response and/or were 
an independent risk factor for preterm birth. For this analysis, inclusion criteria were the 
same as the parent study with the exception that participants were selected from the 
sample if they had a hypertensive disorder.  
Setting 
Three prenatal clinics in Kentucky and Virginia served as recruitment sites in the 
parent study. Four prenatal office visits served as collection periods: 1) 5-13 weeks; 2) 
14-26 weeks; 3) 27-36 weeks gestation, and 4) 2-8 weeks postpartum. At least four weeks 
were allotted between collection points. Enrolled subjects provided demographic 
information and reproductive history. Serum samples for the parent study were obtained 
at each collection point during routine prenatal visits.  
Measures 
In the parent study, serum samples were collected using standard venipuncture. For 
long-term storage, blood samples were centrifuged, pipetted into aliquots, and stored at – 
80o c. Samples were slowly thawed prior to analysis. Cytokine samples were analyzed 
undiluted. All samples were run in duplicate according to manufacturers’ protocols 
(Ashford et al., 2015).  
Systemic inflammation. Systemic inflammation was defined as a response from 
immune-related cells resulting in the release of inflammatory cytokines. A mild maternal 
response is considered normal in pregnancy (Redman & Sargent, 2004). We measured 
systemic inflammation through serum inflammatory biomarkers, specifically pro-
inflammatory cytokines interleukin1α (IL-1α), interleukin 1β (IL-1β), interleukin 6 (IL-
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6), interleukin 8 (IL-8), tumor necrosis factor α (TNFα) and anti-inflammatory 
interleukin 10 (IL-10) using the Luminex system.  
The Luminex system is a highly reproducible and reliable bead-based assay that 
enables quantification of multiple proteins simultaneously (Tighe, Negm, Todd, & 
Fairclough, 2013). The Luminex multiplex bead assay has become an important tool for 
detecting and measuring cytokines due to its ability to measure multiple cytokines 
simultaneously with a small sample size that was not previously possible with older 
technologies (Khalifian, Raimondi, & Brandacher, 2015). When compared to the gold 
standard of cytokine measurement enzyme-linked immunosorbent assay (ELISA), the 
multiplex bead array has a high correlation coefficient ranging from 0.912 – 1.0 (Elshal 
& McCoy, 2006). 
In addition, we collected questionnaire data for several psychosocial variables 
including perceived stress. This data were collected immediately following biomarker 
collection at each time point by trained staff. Questionnaires were given to study 
participants to complete on their own during their office visit. Staff provided verbal 
instructions on how to complete the surveys. Questionnaires were administered via a 
web-based survey or paper copy according to their preference. All written material was 
available in English and Spanish at a 6th grade reading level. Participants received a $20 
gift card after each collection point as an incentive. Women were free to withdraw at any 
time during the parent study.  
 Prenatal Stress. Stress was defined as the maternal psychological stress perceived 
during pregnancy and measured through the Everyday Stressors Index (ESI) Hall (1983). 
The ESI (Hall, et al., 1983) is a 20-item self-report questionnaire used to evaluate 
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perceived stress during perinatal period. ESI consists of a 4-point Likert scale ranging 
from “not at all bothered” to “bothered a great deal”; total scores range from 0-60 with 
higher scores indicating a higher level of stress (Hall et al., 1985). The index assesses five 
common sources of maternal stress such as role overload, financial concerns, parenting 
worries, employment problems, and interpersonal conflicts. The participant reflected the 
number of times an event occurred in their life within the previous year and selected the 
appropriate response. A cumulative score is obtained by summing each item. The 
instrument was developed to measure individual responses to common stressors faced by 
low-income mothers with young children. In samples of mothers of young children, the 
ESI demonstrated strong internal consistency with alphas ranging from 0.81 to 0.86 (Hall 
& Farel, 1988; Hall, Kotch, Browne, & Rayens, 1996; Hall et al., 1985; Peden, Rayens, 
Hall, & Grant, 2004). Content and construct validity of the ESI were also supported in a 
number of studies (Hall, 1983; Hall et al., 1996; Pollock, Amankwaa, & Amankwaa, 
2005). The majority of participants recruited in the parent study fit the low-income 
demographic with 66% insured through Medicaid. 
 Demographic characteristics. Age, race (Caucasian vs. Non-Caucasian), parity, 
marital status, income level, and education level were collected. Demographic data were 
collected through self-report at the first trimester appointment.  
Procedures  
An exemption certification was not required, as the parent study had been closed. 
Cases and controls were frequency matched on age (5 year increments) and parity (yes or 
no) in the same trimester of pregnancy with a 2:1 control to cases ratio. Controls were 
randomly selected normotensive women from the study population based on selected 
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matching described above. Cases involved women who developed a hypertensive 
disorder via medical record during pregnancy. Frequencies were run to determine any 
missing data. Since this a secondary data analysis, missing data was filtered out prior to 
analyses. Race, income level, marital status, and education level was all recoded into 
smaller groups due to sample sizes. The data were markedly skewed. Therefore, 
inflammatory markers were successfully transformed by taking the natural log prior to 
analysis. However, perceived stress score (ESI) could not be successfully transformed 
after numerous attempts so it was categorized into high stress (above 75th percentile) and 
low stress (below 75th percentile) using a cut point of 3. 
Data Analysis  
Preliminary analyses included descriptive statistics to characterize the participants 
in the secondary analysis. Independent t-tests and chi-square tests were used to compare 
study variables between women with a hypertensive disorder (cases) and those without 
(controls). Independent t-tests were used to determine if there were differences in serum 
inflammatory biomarker levels between women with a hypertensive disorder and women 
without the disorder measured in each trimester. There were 21 women with a 
hypertensive disorder and 42 women without a hypertensive disorder with data for each 
trimester used in this analysis. To address the first aim, independent t-tests with an ESI 
score cut-point of 3 (75th percentile) were used to determine if there are differences in 
serum levels of inflammatory biomarkers based on categorized high and low stress in 
each trimester between women who develop a hypertensive disorder and those who do 
not.  
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To address specific aim #2, repeated measures mixed modeling was used to 
discern differences in inflammatory biomarker levels by stress level and hypertension 
status during pregnancy, using the MIXED procedure in SAS. The between subject 
factors for each mixed model included stress level (high/low) and having a hypertensive 
disorder (yes/no) during pregnancy. Each model contained these main effects and the 
main effect of time (trimester), as well as their interactions. In the initial models (one for 
each cytokine), the interaction among stress level, hypertension status, and time was 
tested but removed from each model due to lack of statistical significance. Thus the final 
model for each cytokine contains the main effects and two-way interaction terms. Post-
hoc pairwise comparisons for significant main or interaction effects were accomplished 
using Fisher’s Least Significant Difference procedure. All analysis was conducted with 
SPSS v. 22 and SAS v. 9.4. A priori statistical significance was p ≤ .05.  
Results 
Patient Characteristics 
Participants included in the analysis were 1st trimester hypertensive (n=33) and 
non-hypertensive (n=64), 2nd trimester hypertensive (n=31) and non-hypertensive 
(n=62), and 3rd trimester hypertensive (n=28) and non-hypertensive (n=56). Table 3.1 
illustrates the sociodemographic characteristics and baseline stress scores for this sample 
(n = 97). Per design, this sample consisted of 33 (34%) pregnant women with a 
hypertensive disorder and 64 (66%) without the disorder. The average age for the group 
was 26 years old. The majority of the samples were Caucasian (75%). The majority held 
greater than a high school education (79%). The majority 78% were married or living 
with a partner while 22% of participants were single or not living with a partner. There 
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was a significant difference in marital status between the two groups. More of the sample 
57% had an income greater than $30,000 with the remaining 43% had an income below 
$30,000. There were no differences in baseline stress scores between hypertensive and 
normotensive women in this study.  
Table 3.2 illustrates the average levels of IL-1α, IL-1β, IL-6, IL-8, IL-10, and 
TNF-α and p-values for the subgroup (n = 63) with inflammatory biomarker data in each 
trimester of pregnancy divided by development of a hypertensive disorder or not. There 
were no significant differences in serum levels of these inflammatory biomarkers 
between these two groups in any of the three time points.  
Specific Aim 1 
Table 3.3 illustrates the average levels of IL-1α, IL-1β, IL-6, IL-8, IL-10, and 
TNF-α and p-values for the non-hypertensive group based on high and low stress. There 
were significant differences in the third trimester in serum levels of IL-1β, IL-10, and 
TNF-α with lower levels in the high stress group. Table 3.4 illustrates the average levels 
of IL-1α, IL-1β, IL-6, IL-8, IL-10, and TNF-α and p-values for the hypertensive group 
based on high and low stress. There were significant differences in serum IL-6 in all three 
trimesters with the high-stress group having higher levels. Additionally, IL-8 was 
significantly higher for the high stress group in both second and third trimesters. Finally 
IL-1α was significantly higher for the high stress group in the third trimester. 
Specific Aim 2 
Serum levels across trimesters by stress level 
 Repeated measures models showed significant main effects of stress level 
(high/low) and hypertension status for IL-8 (see Table 3.5). For the inflammatory 
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biomarker with significant stress level main effect, the levels were reduced in those with 
high stress compared to women with low stress. No differences were detected in IL-1α, 
IL-1β, IL-6, IL-10, or TNF-α by stress level, and the interaction between trimester and 
stress level was not significant for these inflammatory biomarkers with the exception of 
IL-1α. 
There was a significant difference in the change of serum IL1- α levels across 
pregnancy between women with high stress and low stress (i.e., significant stress level by 
trimester interaction effect; see Table 3.5). Women with high stress had lower levels of 
IL1-α in the first trimester compared to women with low stress; there were no differences 
between the groups in mid to late trimesters. 
Serum levels across trimesters by stress level and hypertension status 
 Repeated measures models showed a significant difference in the change of serum 
IL-10 levels across pregnancy between women with high stress and a hypertensive 
disorder compared to normotensive women with low stress (i.e., significant stress level 
and hypertension status by trimester interaction effect; see Table 3.5). Serum levels of IL-
10 were significantly higher in the third trimester in women with high stress and a 
hypertensive disorder compared to normotensive women with low stress levels. There 
were no differences detected in the serum IL-1α, IL-1β, IL-6, IL-8, and TNF-α levels and 
the interaction between trimester, stress level, and hypertension status. 
 The main effect of trimester, regardless of stress level or hypertension status, was 
not significant for any of the serum inflammatory biomarker measurements. This 
subsample consisted of 63 women whose stress scores were available for all three 
trimesters. 
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Discussion 
In the present study there were no differences in serum levels of IL-1α, IL-1β, IL-
6, IL-8, IL-10, or TNF-α between women who developed a hypertensive disorder and 
women who did not develop the disorder. Our findings are contrary to those of other 
researchers who found levels of TNF-α were higher in the third trimester for women with 
a hypertensive disorder (Ramma, 2011; Szarka et al., 2010). Increased levels of IL-6 
during the last trimester in hypertensive women have been reported (Ramma, 2011; 
Szarka et al., 2010). Szarka et al. reported elevated circulating IL-1 receptor antagonist 
concentration in women with a hypertensive disorder as an indication of increased levels 
of IL-1α and IL-1β late in pregnancy (2011). Additionally Szarka reported higher levels 
of IL-8 late in pregnancy, a finding contrary to our results.  
Women with low stress scores without a hypertensive disorder had significantly 
higher levels of IL-1β, IL-10, and TNF-α. These finding contradict previous published 
results where IL-1β and IL-6 were higher in women experiencing higher levels of stress 
(Coussons-Read et al., 2007). It is important to mention the measure of stress in this 
study utilized a different instrument that may have not captured the same dimensions as 
the other study. In addition, the women in this study had relatively low stress scores 
while the women in the study by Coussons-Read et al. women equally distributed into 
low, average, and high stress groups.  
Women experiencing a hypertensive disorder and high stress had higher levels of 
IL-6 in all trimesters similar to findings from Coussons-Read et al. (2005), higher levels 
of IL-8 in the second and third trimesters, and higher levels of IL-1α in the third trimester 
than the low stress group.  When Il-8 was averaged over trimester for both groups, serum 
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levels were lower for those women categorized with high stress. To date no studies have 
measured IL-8 or IL-1α in the context of high stress in a hypertensive pregnancy. High 
levels of stress have been previously associated with a high-risk pregnancy such as one 
complicated with a hypertensive disorder (Cardwell, 2013). However, participants in this 
study did not report high levels of stress and a significant difference between the groups 
was not demonstrated. 
Despite hypertension status, there was a significant interaction between stress 
level (high/low) and trimester for IL1-α only; women with high stress had lower levels of 
IL1-α in the first trimester compared to women with low stress. This finding does 
partially support the hypothesis proposed by Coussons-Read et al. that maternal 
perceived stress during the prenatal period has a negative effect on pregnancy outcomes 
by altering the maternal immune response (Coussons-Read et al., 2003). Stress level did 
have an effect on the pro-inflammatory marker IL1-α, but it was not a heightened 
response. 
There was a significant interaction between stress level, hypertension status and 
trimester for IL-10 only. Serum levels of IL-10 were significantly higher in the third 
trimester in women with high stress and a hypertensive disorder compared to 
normotensive women with low stress levels. We do expect IL-10 production to be 
heightened in the third trimester until just prior to onset of labor in normal pregnancy 
(Moreli et al., 2012). However, this finding of an exaggerated anti-inflammatory response 
in the third trimester in hypertensive women with high stress is an indication of 
dysregulation of the inflammatory response and might be a compensatory mechanism 
(Szarka et al., 2010).  
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For this secondary data analysis, inflammatory biomarkers were measured from 
serum. Biomarker levels can also be measured in other mediums such as saliva and 
cervicovaginal fluid. Serum levels may not accurately capture differences between 
women developing a hypertensive disorder from those that do not while other mediums, 
such as cervicovaginal fluid, may be more representative of the physiological maternal 
response.  
Limitations 
As a secondary data analysis, the researcher has no control of the parent study 
rigor or sample population. A diagnosis of a hypertensive disorder was not an integral 
component of the parent study. Therefore, the sample size of women with a hypertensive 
disorder was small, especially when measuring longitudinally losing participants at each 
time point. Due to the sample size, most variables were categorized into smaller groups 
including the measure of stress. Preeclampsia was included in the hypertensive disorder 
group in order to increase the sample size; however, the resulting size was still too small 
and lacked statistical power. Although inflammatory biomarker data were evaluated for 
each trimester, there was variability in the serum measures. This could be due to the six-
week collection window within each trimester; further, these concentrations may vary by 
gestational age.  
Another limitation is the presence of recall bias with this type of study. The ESI is 
based on participant’s recollection of stressful events and therefore an inaccurate 
assessment of their maternal stress might be measured. In addition, self-report and social 
desirability bias may also influence reported results. No other studies examining the 
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association between perceived maternal stress and hypertension during pregnancy used 
this instrument. 
Conclusions 
 This study did not find significant differences between women with a 
hypertensive disorder and those without in either stress levels or biomarker levels. 
However, independently, categorized stress was associated with significant changes in 
biomarker levels at different trimesters of pregnancy for women with a hypertensive 
disorder and those without this disorder. Furthermore, hypertensive women with high 
stress experienced a heightened anti-inflammatory response compared to normotensive 
women with low stress levels, potentially a compensatory mechanism. The association of 
subjective stress and inflammatory biomarkers in the development of a hypertensive 
disorder is complex. Although the exact cause of these disorders is unclear, a 
maladaptation of the maternal immune response has been associated with the 
development of a hypertensive disorder and with a heightened stress response, 
specifically an exaggerated pro-inflammatory response. To understand this relationship 
more clearly further longitudinal studies with a larger sample size are warranted. 
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Tables 
 
Table 3.1. Sample characteristics of women with a hypertensive disorder compared to 
normotensive women  (n = 97) 
Characteristic Hypertensive 
disorder       
(n = 33), 34% 
Normotensive 
(n = 64), 66%  
P-value 
Race 
     Caucasian; n, % 
     Not Caucasian; n, % 
 
25 (76%) 
8 (24%) 
 
48 (75%) 
16 (25%) 
.935 
Education 
      High School or less; n, % 
      Greater than high school; n, %           
 
8 (24%) 
25 (76%) 
 
12 (19%) 
52 (81%) 
.526 
Income 
     ≤ $29,999; n, % 
≥ $30,000; n, % 
 
14 (42%) 
19 (58%) 
 
28 (44%) 
36 (56%) 
.901 
Marital Status 
     Single/not living with partner; n, % 
     Married/living with partner; n, % 
 
3 (9%) 
30 (91%) 
 
18 (28%) 
46 (72%) 
.031* 
Age; mean ± SD 26 ± 4.3 25.9 ± 4.1 .988 
ESI Composite Score (1st trimester); 
mean ± SD 
4.9 ± 7.4 2.3 ± 4.2 .066 
*significant to ≤ .05
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Table 3.2. Mean levels of serum inflammatory biomarkers compared between hypertensive and normotensive groups in each 
trimester 
Mean 
±SD 
(pg/m
L) 
Trimester 1 Trimester 2 Trimester 3 
Hypertension  
(n = 21) 
Normotensive 
(n = 42) 
P-
value 
Hypertension 
(n=21) 
Normotensive 
(n=42) 
P-
value 
Hypertension 
(n=21) 
Normotensive 
(n=42) 
P-
value 
IL-1α 27.2±68.3 
pg/ml 
43.7±212.8 
pg/ml 
.630 16.5±38.6 
pg/ml 
22.2±82.9 
pg/ml 
.870 10.9±24.6 
pg/ml 
15.2±45.8 
pg/ml 
.688 
IL-1β 3.7±9.2 
pg/ml 
5.0±18.6 
pg/ml 
.821 2.7±4.4 pg/ml 3.4±8.7 
pg/ml 
.713 2.3±3.1 
pg/ml 
5.4±12.0 
pg/ml 
.366 
IL-6 60.2±162.2 
pg/ml 
12.6±46.1 
pg/ml 
.264 50.7±152.5 
pg/ml 
12.1±25.7 
pg/ml 
.261 32.7±97.5 
pg/ml 
16.3±34.5 
pg/ml 
.196 
IL-8 15.1±24.1 
pg/ml 
12.8±15.8 
pg/ml 
.366 14.2±22.0 
pg/ml 
20.2±58.9 
pg/ml 
.578 13.4±15.2 
pg/ml 
17.2±20.9 
pg/ml 
.400 
IL-10 48.6±143.4 
pg/ml 
21±38.2 
pg/ml 
.773 41.3±117.2 
pg/ml 
20.6±30.2 
pg/ml 
.462 18.6±32.6 
pg/ml 
16.8±31.1 
pg/ml 
.689 
TNF-
α 
10.6±12.0 
pg/ml 
9.1±6.0 pg/ml .901 11.7±8.9 
pg/ml 
13.4±15.5 
pg/ml 
.622 11.7±6.4 
pg/ml 
14.4±16.3 
pg/ml 
.994 
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Table 3.3. Mean levels of serum inflammatory biomarkers compared between low and high stress scores in each trimester for 
normotensive women 
Mean 
±SD 
(pg/m
L) 
Trimester 1 Trimester 2 Trimester 3 
Low Stress  
(n = 48) 
High Stress 
(n = 13) 
P-
value 
Low Stress 
 (n = 42) 
High Stress     
(n = 12) 
P-
value 
Low Stress        
(n = 35) 
High Stress         
(n = 8) 
P-
value 
IL-1α 7.9±19 122.6±379.1 .308 10.0±26.1 47.3±149.0 .859 23.5±55.5 6.4±10.4 .504 
IL-1β 2.9±5.4 11.2±33.1 .403 4.2±8.9 3.5±9.9 .559 9.3±17.5 .8±.9 .006* 
IL-6 6.3±8.8 29.8±81.8 .624 11.2±19.0 20.7±41.1 .908 21.8±41.2 10.4±27.6 .106 
IL-8 9.7±9.6 22.1±22.9 .074 18.7±59.0 15.4±12.9 .168 16.3±22.1 15.7±19.2 .728 
IL-10 17.4±21.4 25.1±61.8 .123 22.9±33.9 22.7±38.8 .109 33.2±69.5 3.4±3.2 .005* 
TNF-
α 
12.0±11.7 6.7±4.5 .419 13.8±15.6 8.4±6.5 .326 16.5±17.4 8.5±7.2 .039* 
*significant to ≤ .05 
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Table 3.4. Mean levels of serum inflammatory biomarkers compared between low and high stress scores in each trimester for 
hypertensive women 
Mean 
±SD 
(pg/m
L) 
Trimester 1 Trimester 2 Trimester 3 
Low Stress        
(n = 20) 
High Stress        
(n = 10) 
P-
value 
Low Stress         
(n = 19) 
High Stress     
(n = 7) 
P-
value 
Low Stress        
(n = 14) 
High Stress         
(n = 11) 
P-
value 
IL-1α 16.8±43.0 51.6±94.7 .271 8.0±18.5 29.5±60.7 .322 3.8±9.6 39.2±77.7 .048* 
IL-1β 3.4±6.7 6.1±13.0 .762 2.9±4.5 2.2±3.6 .981 2.0±3.5 3.1±4.4 .284 
IL-6 14.7±30.9 122.7±223.9 .012* 10.6±28.6 129.7±253.3 .001* 5.6±8.1 63.2±132.2 .025* 
IL-8 17.0±31.5 26.6±31.6 .140 10.8±21.5 19.1±14.5 .034* 9.7±14.6 18.5±17.1 .050* 
IL-10 21.0±34.4 79.5±206.3 .998 45.5±123.3 12.0±8.1 .850 13.6±17.1 100.6±268.8 .563 
TNF-
α 
9.1±8.1 13.9±16.5 .380 10.0±5.3 13.2±14.2 .675 12.2±6.5 11.3±8.5 .496 
*significant to ≤ .05 
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* significant to ≤ .05  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5. Repeated measure models for each inflammatory biomarker with 
main effects of hypertension (yes/no), stress (high/low) and trimester  
                                                                            Serum      
                                                                          F                       p 
IL-1α 
Hypertension Status 
Stress Level 
Trimester 
Stress x Trimester 
 
0.01 
2.17 
2.5 
5.0 
 
0.93 
0.14 
0.09 
0.008* 
IL-1β 
Hypertension Status 
Stress Level 
Trimester 
 
0.08 
0.01 
1.13 
 
0.78 
0.92 
0.32 
IL-6 
Hypertension Status 
Stress Level 
Trimester 
 
3.39 
2.72 
0.36 
 
0.07 
0.10 
0.70 
IL-8 
Hypertension Status 
Stress Level 
Trimester 
 
0.02 
7.57 
0.67 
 
0.88 
.007* 
0.51 
IL-10 
Hypertension Status 
Stress Level 
Trimester 
Stress x Hypertension x Trimester 
 
0.08 
3.72 
0.15 
3.33 
 
0.78 
0.06 
0.86 
0.04* 
TNF-α 
Hypertension Status 
Stress Level 
Trimester 
 
0.25 
0.80 
2.0 
 
0.62 
0.37 
0.14 
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Figure 3.1. Theoretical Framework Illustrating Factors Associated with the Development 
of Preeclampsia Symptoms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perceived 
Stress 
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Chapter IV: A Review of the Association of Psychological Distress with the 
Development of a Hypertensive Disorder during Pregnancy 
 
Background and Significance 
Hypertensive disorders complicate up to 10% of pregnancies and are associated 
with higher rates of maternal and fetal morbidity and mortality (American College of 
Obstetricians and Gynecologists, 2013). Hypertensive disorders consist of several 
classifications including chronic hypertension, gestational hypertension, preeclampsia, 
and chronic hypertension with superimposed preeclampsia. A World Health Organization 
review identified these disorders as the leading cause of maternal mortality accounting 
for 16% of deaths in industrialized countries (Khan, Wojdyla, Say, Gülmezoglu, & Van 
Look, 2006), and are associated with an increased risk of stillbirth (Hutcheon, Lisonkova, 
& Joseph, 2011). In addition, women with preeclampsia are at an increased risk (10-30% 
higher) for severe complications including acute renal failure and pulmonary edema 
(Wallis, Saftlas, Hsia, & Atrash, 2008). Infants of mothers with preeclampsia are at two 
times increased risk of low Apgar scores and three to four times increased risk of being 
small for gestational age, an effect that is more pronounced at preterm gestation than term 
(Hutcheon et al., 2011). Given the severity of these disorders, understanding the etiology 
of hypertensive disorders remains an important objective. 
 Overall, the exact etiology of hypertensive disorders, including preeclampsia, is 
unknown. However, there are physiological (immunity and placental ischemia) and 
psychological (stress, anxiety, depression) factors that have been associated with the 
development of these complex disorders (Lazdam et al., 2011). Furthermore, 
psychological stress has been directly associated with the development of a hypertensive 
disorder (Franco et al., 2015; Kurki et al., 2000; Qiu et al., 2009) as well as through 
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altering maternal immune function. Vianna et al., (2011) hypothesized that distress 
conditions including stress, anxiety, and depression can induce a hypertensive disorder in 
part through maternal dysregulated immunity (Vianna et al., 2011). Prior research has 
focused on one component of psychological distress, primarily stress and the associations 
among women experiencing a subsequent development of a hypertensive disorder during 
pregnancy (Klonoff-Cohen, Cross, & Pieper, 1996; Landsbergis & Hatch, 1996; Yu et al., 
2013). Psychological distress includes stress but also anxiety and depression. Studies 
have reported on all three components to varying degrees. 
Prevalence of psychological distress in pregnancy have been reported between 13 
and 25% (Çapik & Pasinlioglu, 2015). Breaking psychological distress into components, 
antenatal depression has a reported prevalence of 14 – 23% (Yonkers et al., 2009); 
estimates of antenatal anxiety are not known; however, women have reported anxiety 
during pregnancy (Schetter & Tanner, 2012), and the March of Dimes reported nearly 
75% of women experienced at least one stressful event in the 12 months prior to delivery 
(March of Dimes, 2015). 
There has been a breadth of studies describing both independent and multiple 
(two or more) psychological distress factors associated with hypertensive disorders 
during pregnancy. Of the studies examining an independent psychological distress factor, 
maternal stress has been the most researched. In a recently submitted review Kehler 
(2016) identified stress as a risk factor in the development of a hypertensive disorder 
(Kehler, 2016). Greater perceived lifetime stress and stress during pregnancy were 
associated with an increased risk of preeclampsia (OR, 2.1; CI, 1.6 – 2.9 and OR, 1.7; CI, 
1.3 – 2.2) (Yu et al., 2013), Furthermore, stress was associated with the progression of a 
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hypertensive disorder during pregnancy. Stress levels were significantly higher in women 
with worsening symptoms of preeclampsia compared to those women with a milder 
condition (Black, 2007). Similar to these findings, a published meta-analysis of 12 
studies examining the association of maternal stress and preeclampsia reported, mental 
stress was associated with an increased risk of preeclampsia (OR, 1.49; CI, 1.27 – 1.74, p 
< 0.001) and pooling 4 studies using gestational hypertension as the outcome showed 
similar results (OR, 1.26; CI, 1.00 – 1.59, p = 0.047) (Zhang et al., 2013). Mental stress 
was defined as work stress, job strain, pregnancy-related stress, life stress, perceived 
stress, and psychosocial stress (Zhang et al., 2013). Due to the majority of published 
research focusing on stress and the author’s recent review of stress, the author will report 
findings from this study breadth and stress will not be a primary component of this 
review.   
 There were fewer studies (n= 6) describing the association between depression 
and/or depressive symptoms and prenatal hypertensive disorders, and of those, results 
were conflicting. While three studies did support a relationship between depression and 
the development of a hypertensive disorder (Franco et al., 2015; Kurki et al., 2000; Qiu et 
al., 2009) three others did not (Andersson, Sundström-Poromaa, Wulff, Åström, & Bixo, 
2004; Thombre, Talge, & Holzman, 2015; Vollebregt et al., 2008). 
Maternal anxiety during pregnancy has received the least attention of the 
psychological distress factors contributing to the development of a hypertensive disorder 
when compared to maternal stress and depression. Prior studies suggest that anxiety 
symptoms may develop or be exacerbated during pregnancy (Breitkopf et al., 2006). 
However, results vary with three studies’ results supporting a relationship between 
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anxiety and the development of a hypertensive disorder (Franco et al., 2015; Kurki et al., 
2000; Qiu et al., 2009) and four that did not find a significant association (Andersson et 
al., 2004; Sikkema et al., 2001; Thombre et al., 2015; Vollebregt et al., 2008). 
Although researchers have reported on psychological distress, few have utilized a 
conceptual framework in their studies. A conceptual framework would organize ideas and 
identify key relationships between variables. Since stress, a component of psychological 
distress has been shown to increase the risk of developing a hypertensive disorder during 
pregnancy and anxiety and depression can be related to stress and are components of 
psychological distress; it seems pertinent to investigate any relationship between 
depression and/or anxiety in a hypertensive disorder. The purpose of this paper was to 
operationally define the components of psychological distress, identify the prevalence of 
psychological distress, and examine any associations of psychological distress with the 
development of a hypertensive disorder during pregnancy. The specific aims were as 
follows: 
1) Investigate three primary components of psychological distress within a 
conceptual framework during pregnancy 
2) Determine the prevalence of the least investigated components of 
psychological distress (anxiety, and depression) with the development of a 
hypertensive disorder 
3) Examine and evaluate the literature combining at least two components of 
psychological distress (stress, anxiety and depression) with the development of a 
hypertensive disorder during pregnancy.  
 57  
 
In this paper, hypertensive disorders in pregnancy include gestational hypertension and 
preeclampsia.  
Concepts of Psychological Distress and Conceptual Framework 
Prior to reviewing the literature, it was important to operationally define the 
concepts of maternal stress, anxiety, and depression in the context of pregnancy including 
pregnancy complications and identify a conceptual framework to direct the study. 
Stress: Selye (1956) defined stress as the representation of the effects of anything 
that threatens homeostasis. The actual or perceived threat is a stressor, and the response 
to the stressor is the stress response (Selye, 1956). Since then, many terms and labels for 
stress have been used, measured, and reported in the literature; however, conceptual and 
operational definitions are often not provided. For example, Sikkema et al., measured 
‘psychological stress’ using salivary cortisol and measured anxiety but did not provide a 
definition for psychological stress (Sikkema et al., 2001). Terms used to describe stress 
included ‘general life stress’, ‘perceived stress’, ‘violent events’, ‘work stress’, ‘job 
stress’, ‘chronic stress’, ‘psychosocial stress’, ‘general distress’, and ‘pregnancy-specific 
stress’ (Christian, 2012a; Klonoff-Cohen et al., 1996; Landsbergis & Hatch, 1996; 
Schetter & Tanner, 2012; Yu et al., 2013).  Still other’s report stressors, or strain to 
describe the emotional experience that initiates a response (Schetter & Tanner, 2012).  
Differing conceptual definitions of maternal stress during pregnancy pose limitations 
when comparing studies. In addition, various self-report instruments are utilized to assess 
the associated symptoms for a multitude of stress concepts leading to difficulties in 
interpreting and comparing severity of the symptoms among articles. The National 
Institution of Mental Health (NIMH) defines stress as the brain’s response to any demand 
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(U. S. Department of Health and Human Services). Stress can be caused by routine 
stressors such as work, family, and other daily responsibilities or hassles. Stress can also 
be caused by non-routine stressors such as a sudden change like losing a job or having an 
illness or by a major event like a natural disaster or assault (U. S. Department of Health 
and Human Services). For the purposes of this review the operationalized definition of 
stress is a psychological feeling of pressure from a stressor. This definition is inclusive 
and incorporates pressure from all three categories defined by NIMH.  
Anxiety: The NIMH defines anxiety as temporary worry or fear. It can be 
characterized as either state (how an individual feels right now) or trait (evaluates an 
individuals’ propensity for anxiety) (Julian, 2011). General anxiety can be measured with 
several validated self-report instruments commonly used to assess symptom severity. An 
anxiety disorder occurs when the fear or worry does not go away and can get worse over 
time and these feelings may start to interfere with everyday life and relationships (U. S. 
Department of Health and Human Services, 2016a). In addition, exposure to stressful life 
events is a risk factor for the development of an anxiety disorder. Assessing an anxiety 
disorder requires other measures used to evaluate specific diagnostic criteria for each 
disorder. Anxiety has fewer; more clearly defined terms and associated symptoms. For 
the purpose of this review all levels of anxiety were included.  
Depression: The NIMH defines depression as experiencing some of the following 
symptoms: persistent sad or anxious moods, feelings of hopelessness, worthlessness, 
fatigue, loss of interest in hobbies, and activities, difficulty sleeping, among others (U. S. 
Department of Health and Human Services, 2016b). Depression is a common mood 
disorder on a continuum based on time and severity of symptoms. Perinatal depression 
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can also be mild to severe and be experienced during pregnancy or after the birth of their 
baby.  Several self-report instruments have been validated for use in measuring the 
severity of depressive symptoms and a few are frequently used in the literature regarding 
depression during pregnancy. Maternal depression during the perinatal period rather than 
the postpartum period was examined in this review.  
A concept analysis by Emmanuel and St. John (2010) provided some clarity in the terms 
often used to describe maternal distress. Again, several terms were used in lieu of the 
term “maternal distress”, however few provided conceptual definitions. Terms used 
including: ‘distress’, ‘mental distress’, ‘distressed mood’, psychological distress’, 
‘emotional distress’, ‘prenatal maternal stress’, and ‘depressive and anxiety symptoms’ 
(Emmanuel & St John, 2010). Although several terms were used to describe the 
phenomenon, the emerging themes included stress or distress, depression and anxiety 
(Emmanuel & St John, 2010). The authors go on to define maternal distress as a 
continuum including the stress response as either stress (worry, concern, mild anxiety) as 
mild distress to anxiety and depression (unhappy, low mood, highly anxious) as high 
distress (Emmanuel & St John, 2010). The continuum model is ideal as symptoms of 
stress, anxiety, and depression can overlap without clear separations. For the purposes of 
this review, psychological distress will describe any point on this continuum and is 
comprised of stress, anxiety, and depression.  
Conceptual Framework: The concept of psychological distress fits in with the 
Psychoneuroimmunology (PNI) model in pregnancy put forth by Christian (2011). The 
PNI model incorporates psychological distress with maternal health, birth outcomes, and 
fetal development through maternal immune parameters. The PNI model includes 
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stressors, coping resources as moderators, the resulting psychological distress and the 
health behaviors associated, the resulting immune response, and lastly maternal health 
and pregnancy outcomes (Christian, 2012b). The components of psychological distress 
include stress, anxiety, and depression. The maternal outcome is not specified but for this 
review, the outcome is a hypertensive disorder. The original model did not address any 
direct links between psychological distress and maternal health, but evidence has 
supported a relationship between these two factors; therefore, it is that relationship the 
author is investigating in this review (Yu et al., 2013). Figure 4.1 contains the PNI 
framework with the relationships studied for this review. 
Literature Search Strategy 
The author conducted a search for published, peer-reviewed, English language, 
primary research articles using the electronic databases Medline, CINAHL, Psychology 
and Behavioral Sciences Collection, and PsychINFO and following the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 
(Liberati et al., 2009). Initial key search and MeSH terms included preeclampsia or 
pregnancy-induced hypertension or PIH; self-reported stress or maternal stress or 
perceived stress or stress, psychological; anxiety; and depress*. Subsequent searchers 
were conducted with preeclampsia or pregnancy-induced hypertension or PIH and each 
of the other terms independently. Inclusion criteria were as follows: quantitative or 
qualitative research studies on the relationship between at least two of the following self-
reported, perceived, and/or psychosocial stress, anxiety, and/or depression in adult 
women with a hypertensive disorder during pregnancy and study occurred during 
pregnancy. The search was limited to current literature, published between January 2008 
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and 2016 (present) to reveal the most recent knowledge. The start date of 2008 was based 
upon the first located article to include at least two of the psychological stress variables. 
The aforementioned criteria yielded 152 articles. After deleting duplicates, 129 remained. 
The remaining titles and abstracts were screened for suitability leaving 27 for full text 
review. A hand search of references resulted in the addition of three more articles. 
Studies were excluded if performed after delivery, measured newborn/child outcomes, if 
study included substance abuse, rape, intimate partner violence or was associated with a 
natural disaster, or identified stress, depression, and/or anxiety prior to conception. 
Following full text review, seven articles remained that met inclusion criteria for this 
review. See Figure 4.2 for a diagram of the decision-making process. 
A matrix table of the selected articles organized the literature (Table 4.1). The 
matrix table headings included: author, year, and title, setting and design, sample and 
time of assessment, measures, results, strengths and limitations, and variables controlled.  
Findings from the literature were synthesized, summarized, and critically appraised to 
expose current gaps in the literature and recommendations for future research. 
Results 
Characteristics of Studies Reviewed 
 There was a significant lack of studies that included at least two aspects of 
psychological distress; therefore, the search was expanded to include 15 years (2000 and 
2015). Seven studies met inclusion, and represented five countries including the United 
States, Netherlands Finland, Sweden, and Brazil. The common aim shared among the 
studies was to examine the relationship of psychological distress and the development of 
a hypertensive disorder during pregnancy. The primary study characteristics for this 
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review included study design, sample features and time point of measurement, measures 
used, results, and limitations. Table 4.1 provides a description of the study characteristics 
included in this review.   
While the type of study was the same for the seven studies, methods differed. Of 
the reviewed studies, researchers used a quantitative design. The majority of the studies 
were limited through utilizing a cross-sectional prospective study design (Andersson et 
al., 2004; Franco et al., 2015; Kurki et al., 2000; Thombre et al., 2015; Vollebregt et al., 
2008); whereas Sikkema et al’s study was strengthened by using a case controlled 
longitudinal design (Sikkema et al., 2001). In these studies, researchers set significance a 
priori at p = 0.05. A fundamental weakness was a lack of conceptual framework to guide 
any of the research presented in this review. Recruitment methods varied; some women 
were recruited from hospitals during ultrasound visits, prenatal clinics, along with 
obstetrics and gynecology clinics.  
Sample sizes and features differed among the studies. A total of 9,892 women 
participated in the seven studies and the sample size ranged from 18 to 3679. The studies 
included a mix of social demographics. Study participants were all white or a majority 
were white women (Kurki et al., 2000; Qiu et al., 2009; Sikkema et al., 2001) while 
others were more ethnically diverse (Franco et al., 2015; Thombre et al., 2015; 
Vollebregt et al., 2008), or race was not reported (Andersson et al., 2004). Most women 
were married, did not smoke, worked and had an income larger than the minimal wage 
per capita (Andersson et al., 2004; Franco et al., 2015; Kurki et al., 2000; Qiu et al., 
2009; Vollebregt et al., 2008) with the exception of one study where more than half of the 
women were on Medicaid (Thombre et al., 2015). The women in three of the studies were 
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nulliparous (Kurki et al., 2000; Qiu et al., 2009; Sikkema et al., 2001; Vollebregt et al., 
2008) while three included women who have given birth before (Andersson et al., 2004; 
Franco et al., 2015; Thombre et al., 2015). Data collection time points varied as well. 
Women were approached for recruitment and measures were taken beginning at 10 weeks 
gestation through the third trimester.  
Psychological Distress Measures  
 The components of psychological distress were assessed almost exclusively by 
subjective, self-report measures (Andersson et al., 2004; Franco et al., 2015; Kurki et al., 
2000; Sikkema et al., 2001; Thombre et al., 2015; Vollebregt et al., 2008). A few relied 
on medical record evaluations (Franco et al., 2015; Qiu et al., 2009), and one included a 
structured interview by the provider after participants completed a questionnaire 
(Andersson et al., 2004). Measures of a hypertensive disorder during pregnancy were 
gathered through medical records for most of the studies except for one that assessed 
“momentary hypertension” through the use of a digital blood pressure monitor (Franco et 
al., 2015). Sikkema et al. strengthened their study by including a biological measure for 
psychological distress in addition to the self-report measures (Sikkema et al., 2001). 
 Stress Measures: Only one form of stress was evaluated in these studies. Work 
stress was examined using four scales; reliability and validity were not mentioned for any 
one instrument but Cronbach’s α was given for the total scale (Vollebregt et al., 2008).  
 Depression Measures: Depression was measured or assessed with a few self-
report instruments, medical records, or questions asked to study participants. Studies 
were strengthened through using well-known instruments such as Beck Depression 
Inventory (BDI) (Kurki et al., 2000) and the Center for Epidemiologic Study Depression 
 64  
 
(CESD) scale (Thombre et al., 2015; Vollebregt et al., 2008) and provided evidence of 
reliability using Cronbach’s α as well as validity (Kurki et al., 2000; Vollebregt et al., 
2008). In one study, however, depression was included as a variable but the authors did 
not mention how they assessed participants for depression (Franco et al., 2015). 
Depression was also evaluated using the Primary Care Evaluation of Mental Disorders 
Patient Health Questionnaire and reported as “has been validated for use in obstetric-
gynecologic patients” (Andersson et al., 2004).  
 Anxiety Measures: Anxiety was primarily measured with the State - Trait Anxiety 
Inventory (STAI) questionnaire, English and Dutch versions (Franco et al., 2015; 
Sikkema et al., 2001; Vollebregt et al., 2008). When reliability was reported, it was 
through using Cronbach’s α; yet others did not report reliability. Few used the state 
measure (Franco et al., 2015; Vollebregt et al., 2008) while one used both state and trait 
scores (Sikkema et al., 2001). Two studies measured pregnancy specific anxiety using an 
abbreviated version of the pregnancy-related anxiety questionnaire (PRAQ) and the 
author’s provided validity data in the form of factor analyses and reliability using 
Cronbach’s α (Sikkema et al., 2001; Vollebregt et al., 2008). Studies were weakened 
when they did not use valid instruments to assess anxiety or relied on medical records 
(Kurki et al., 2000; Qiu et al., 2009; Thombre et al., 2015). Anderson et al. measured a 
more severe form of anxiety. Anxiety disorders were assessed using the Primary Care 
Evaluating of Mental Disorders Patient Health Questionnaire; however, evidence of 
validation was not reported rather stated by the authors as “has been validated for use in 
obstetric-gynecologic patients” (Andersson et al., 2004). Sikkema et al. strengthened their 
study by including a biological measure of psychological stress (Sikkema et al., 2001). 
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Salivary cortisol was assessed for correlation to anxiety levels since it is a hormone that 
is excreted in excess during times of psychological stress. The authors provided 
sensitivity of equipment measuring cortisol levels. 
 Hypertensive Disorders in Pregnancy Measures: Preeclampsia and gestational 
hypertension were the two disorders included in this review. Preeclampsia was most 
often diagnosed after having diastolic blood pressure (DBP) ≥ 90 mmHg or systolic 
blood pressure (SBP) ≥ 140 mmHg on at least two different calendar days plus evidence 
of proteinuria (≥ 300 mg per 24 hrs.) after 20 weeks gestation. Gestational hypertension 
has the same diagnostic criteria without proteinuria. Slight variations in diagnostic 
criteria were only using DBP (Vollebregt et al., 2008), DBP of 100 mmHg (Kurki et al., 
2000), only having one measure of blood pressure (Franco et al., 2015), or relying on 
medical record without specifying criteria (Qiu et al., 2009). 
Study Findings 
 In total, seven studies have investigated the role of higher levels of at least two 
components of psychological distress (stress, anxiety, and/or depression) in the 
development of a hypertensive disorder during pregnancy with conflicting results. While 
significant positive associations between a measure of psychosocial distress and the 
development of a hypertensive disorder during pregnancy were found (Franco et al., 
2015; Kurki et al., 2000; Qiu et al., 2009); conversely, there was research that did not 
support this finding (Andersson et al., 2004; Sikkema et al., 2001; Thombre et al., 2015; 
Vollebregt et al., 2008).  
Studies reporting a positive association between psychological distress and a 
hypertensive disorder provided different statistical evidence.  Women experiencing 
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higher levels of anxiety were more likely to have hypertension compared to women 
without anxiety (p = 0.049) (Franco et al., 2015). Women were also at an increased risk 
for developing a hypertensive disorder in the presence of a psychological distress (Franco 
et al., 2015; Kurki et al., 2000; Qiu et al., 2009).  Associations between psychological 
distress and a hypertensive disorder were found at various times during pregnancy. In 
these latter studies, depression and anxiety were assessed at varied times during 
pregnancy: including two between the first and second trimester (Kurki et al., 2000; Qiu 
et al., 2009), and  another in the third trimester (Franco et al., 2015). In a Finnish cohort, 
elevated depression scores as well as anxiety scores assessed at a median of 12 weeks 
gestation (first trimester) were associated with an increased risk for preeclampsia 
(adjusted OR 2.5, CI: 1.4 – 5.4) and (OR 3.2, CI: 1.4 – 7.4) respectively (Kurki et al., 
2000). Similarly, Qiu et al., (2009) reported an increased risk of developing a 
hypertensive disorder when prenatal depression or anxiety was diagnosed prior to 20 
weeks gestations (second trimester) (adjusted RR 2.12, CI: 1.02 – 4.45; p = 0.045). 
Additionally, women diagnosed with a depressive disorder alone were also at an 
increased risk (RR 2.72, CI: 1.29 – 5.74; p = 0.009).  
 Study results did not always support a positive association between psychological 
distress and the development of a hypertensive disorder. The majority of the studies (n=4) 
that combined two psychological distress measures did not find an association. Anxiety 
or depression assessed between 16 and 27 weeks gestation had no effect on the 
development of a hypertensive disorder during pregnancy (Andersson et al., 2004; 
Thombre et al., 2015; Vollebregt et al., 2008). Vollebregt et al. (2008 ) reported  maternal 
stress (operationalized as work stress) did not increase the risk of developing a 
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hypertensive disorder after adjustment of covariates (Vollebregt et al., 2008). Finally, 
neither of the two measures of anxiety (STAI or PRAQ-R) nor salivary cortisol levels 
were different in women who developed a hypertensive disorder when compared to 
controls, regardless of gestational ages (Sikkema et al., 2001).  
 Prevalence of the components of psychological distress varied in these studies as 
well. Four of the studies reported depression prevalence and four reported anxiety 
prevalence. The prevalence of depression ranged from 4.2 to 35% (Andersson et al., 
2004; Kurki et al., 2000; Qiu et al., 2009; Thombre et al., 2015), anxiety 1.2 to 16% 
(Andersson et al., 2004; Franco et al., 2015; Kurki et al., 2000; Qiu et al., 2009). It is 
important to note the lowest prevalence for both anxiety and depression was with the 
diagnosis of a disorder.  Additionally, one study reported 92% of those in their study had 
an anxious personality, but they did not specify what cut-off was used to determine an 
anxious personality (Franco et al., 2015). Also, the high prevalence did not translate into 
their tables so determining the actual prevalence was not possible. 
Strength and Limitations of Evidence 
 The studies reviewed had several strengths as well as limitations. The strengths 
included timing of data collection, using control groups, controlling for confounding 
variables, and using valid instruments for measuring psychological distress. Assessing 
psychological distress prior to the symptoms of a hypertensive disorder i.e. before 20 
weeks gestation (Andersson et al., 2004; Kurki et al., 2000; Qiu et al., 2009; Sikkema et 
al., 2001; Thombre et al., 2015) allows the researcher to examine the risk factors for the 
development of the disease. Another strength was the use of control groups; however, the 
sample sizes varied considerably. A strength of most of the studies was controlling for 
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variables that were associated with the development of a hypertensive disorder. Variables 
controlled included pre-pregnancy BMI, age, and ethnicity (Qiu et al., 2009; Thombre et 
al., 2015; Vollebregt et al., 2008). Two did not include race since their sample was all 
white (Andersson et al., 2004; Kurki et al., 2000). Others controlled for smoking as well 
(Andersson et al., 2004; Kurki et al., 2000; Thombre et al., 2015; Vollebregt et al., 2008). 
Lastly, strengths of some of the studies reviewed were the measures used to collect the 
data. Valid instruments for measuring psychological distress were used by several 
researchers (Kurki et al., 2000; Sikkema et al., 2001; Thombre et al., 2015; Vollebregt et 
al., 2008). Furthermore, Vollebregt et al. (2008), strengthened their study by completing a 
comprehensive evaluation of psychological stress during pregnancy by measuring 
depression, anxiety, and work stress; yet another strengthened their study through the use 
of a biological measure (Sikkema et al., 2001) The biological measure did demonstrate 
reliability. The method for collecting salivary cortisol was reliable by following a 
demonstrated salivary protocol for collecting and storing saliva and testing cortisol levels 
(Sikkema et al., 2001).  
 Another strength of all but one of the studies was the diagnosis of a hypertensive 
disorder was verified through medical records and not reliant on self-report. However, 
one study did not meet the criteria for gestational hypertension having relied on one 
measure of blood pressure at one time point (Franco et al., 2015).   
There were also limitations in the studies reviewed. Limitations included data 
collection timing, sample sizes, and measures used to collect data. Timing of data 
collection was a limitation when there was a potential overlap of the development of the 
hypertensive disorder and collection of the psychological distress data (Franco et al., 
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2015; Vollebregt et al., 2008).While prospective design allows for a predictive model for 
the development of a hypertensive disorder during pregnancy; when data collection 
occurred after 20 weeks gestation, there was a chance the women may have had 
preeclampsia prior to the collection of psychological distress and having the condition 
could alter their responses to the assessment. There was another limitation to collecting at 
one time point. Assessing psychological distress at one time point fails to capture any 
changes in the levels of this distress. For example, it was impossible to determine if 
increasing severity of stress, depression, and/or anxiety correlate with the severity of the 
hypertensive disorder in pregnancy in most of these studies (Andersson et al., 2004; 
Franco et al., 2015; Kurki et al., 2000; Qiu et al., 2009; Thombre et al., 2015; Vollebregt 
et al., 2008).  
 Another limitation was sample size. Most of the studies had small sample sizes 
ranging from 9 – 66 women who developed a hypertensive disorder (Andersson et al., 
2004; Franco et al., 2015; Kurki et al., 2000; Qiu et al., 2009; Sikkema et al., 2001). One 
study had a large sample size of 289 with a hypertensive disorder, but after separating in 
to low, moderate, and high levels of psychological stress the confidence intervals of the 
risk estimates were large and odds ratios failed to reach statistical significance 
(Vollebregt et al., 2008).  
 Lastly, the measures used to collect the data were a limitation. Researchers relied 
on self-reported data without clinical or biological verification (Andersson et al., 2004; 
Franco et al., 2015; Kurki et al., 2000; Sikkema et al., 2001; Thombre et al., 2015; 
Vollebregt et al., 2008). Some did not provide cut-off scores of instruments used (Franco 
et al., 2015; Vollebregt et al., 2008), most did although one score used was very low. 
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Kurki et al. utilized a modified BDI and a very low cut-off score of three as an indication 
of depression. Thus their prevalence of depression during pregnancy was 30%; an 
amount higher than the 14% reported by the American College of Obstetricians and 
Gynecologists (ACOG) thereby possibly altering the positive predictive value. 
Furthermore, Franco et al. did not rely on the ACOG definition of hypertensive disorders 
in pregnancy, but assessed blood pressure at one time point and used this measure in their 
analysis (Franco et al., 2015). 
Risk of Bias 
Several study biases exist in the reviewed studies, including sampling and 
observational bias, and use of self-reported measures. A common bias with these studies 
results from using convenience samples and not a population sample. This is a common 
finding in research with pregnant women due to pregnancy’s transient nature but leads to 
the inherent problems of sampling bias and generalizability of results to a population. 
Inconsistent timing of measurement across studies and the use of cross-sectional data 
used in most of the studies increase the risk of observational bias. Without the ability to 
detect change over time, there was no way to assess the stability or instability of a 
particular psychological distress component. Self-reporting can lead to underestimating 
or overestimating a condition without any clinical or biological verification, and was only 
reported as a limitation in one study (Vollebregt et al., 2008).  The limited use of 
biomarkers associated with psychological distress reviewed in these studies is 
noteworthy, as Sikkema et al. (2001) was the only study to use a biological measure to 
correspond with reported anxiety. 
 
 71  
 
Discussion 
According to the PNI framework during pregnancy, three primary components of 
psychological distress are stress, anxiety, and depression. Additionally, those components 
have been shown to have an effect on the development of a hypertensive disorder in some 
studies, while others did not support this claim. The association of psychological distress 
with the development of a hypertensive disorder remains unclear, likely due to 
differences in study design and operational differences of psychological distress.  
Differences in study design including time point of assessment, sample size and 
controlled variables may account for conflicting results. Of the reviewed studies, a cross-
sectional design was the most frequent; however, the time point of assessment altered 
with the studies. Most of the studies assessed psychological distress in the first or early in 
the second trimester (Andersson et al., 2004; Kurki et al., 2000; Qiu et al., 2009; 
Thombre et al., 2015), while others assessed late second trimester or into third trimester 
(Franco et al., 2015; Vollebregt et al., 2008), and still another assessed before and after 
the potential development of symptoms (Sikkema et al., 2001). Furthermore, some 
studies held a tight window for assessment 1 to 2 weeks (Andersson, Sikkema, Thombre), 
one a more open window, 10-17 weeks (Kurki et al.) and others were anytime after a 
specific gestational age (Vollebregt, Qiu, Franco). The wide distribution of assessment 
points makes comparison of results difficult. Additionally, there was a lack of studies 
with assessments at more than one time point. Psychological distress changes throughout 
pregnancy. Depression levels fluctuated in each trimester, peaking in the second trimester 
(Bennett, Einarson, Taddio, Koren, & Einarson, 2004). Measuring psychological distress 
at one time point would not capture these changes. Sample sizes and prevalence rates 
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differed among these studies. Prevalence rates of depression ranged from 4.2 to 35%, and 
anxiety 1.2 to 16% (Andersson et al., 2004; Franco et al., 2015; Kurki et al., 2000; Qiu et 
al., 2009; Thombre et al., 2015). Small prevalence rates for psychological distress and the 
development of a hypertensive disorder may have led to difficulty in demonstrating 
significance especially at the highest levels of stress, anxiety, and depression (Sikkema et 
al., 2001; Thombre et al., 2015). Moreover, while most controlled for confounding 
variables, psychotropic medications were not controlled for during data analysis (Qiu et 
al., 2009) and these type of medications have been independently associated with an 
increased risk of preeclampsia (Palmsten, Setoguchi, Margulis, Patrick, & Hernández-
Díaz, 2012). 
Differences were also noted with the operationalized definitions of psychological 
distress leading to differences in study results. Instruments were used in this review such 
as BDI, CESD, STAI, PRAQ-R, thereby operationalizing stress, anxiety, and depression 
differently. For example Sikkema et al. (2001), operationalized anxiety as associated with 
pregnancy and measured with the PRAQ-R differing from state anxiety where anxiety 
can occur from other stressors not related to pregnancy. In addition, levels of 
psychological distress were not the same in each study. An example was in Kurki et al’s 
use of a low cut-off point increasing the prevalence of the psychological distress; still 
others did not provide evidence of validity in their selected instruments or relied on 
medical records (Franco et al., 2015; Kurki et al., 2000; Qiu et al., 2009; Thombre et al., 
2015).   
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Limitations 
Limitations in this review may have also contributed to lack of consensus. The 
search methodology may have limited the number of studies identified for inclusion. The 
author was interested in psychological distress and therefore included only those studies 
that measured at least two components of psychological distress. In doing so, the only 
form of stress identified was in the form of routine stressors and was work related stress. 
Specifically, the search terms used may not have been inclusive enough to capture all the 
articles published on this topic. Another limitation was restricting hypertensive disorders 
to just preeclampsia and gestational hypertension omitting other disorders. 
Recommendations for Future Research 
Future research should consider study design, using a conceptual framework, use 
of valid instruments and pay careful attention to the components of psychological 
distress.  In considering study design, longitudinal cohort studies with prospective 
maternal assessment are preferred. However due to the prevalence of a hypertensive 
disorder during pregnancy with concurrent symptoms of psychological distress, a case-
control method may offer the best approach.  Using an appropriate conceptual framework 
is also important to guide future studies. The purpose of a conceptual framework is to 
identify the variables central to the study and a framework for interpreting results. The 
psychoneuroimmunology framework in pregnancy could serve this purpose. Finally, the 
use of valid instruments and a biological or clinical measure in assessment of 
psychological distress is suggested. Discrimination between levels of anxiety and 
depression and general levels of stress cannot be easily assessed. These concepts overlap 
and include mood and anxiety disorders. They are often comorbid conditions as well. 
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Therefore, it is important to carefully assess each component of psychological distress 
with the appropriate validated measure. Using reliable and measurable instruments of 
psychological distress along with a biological measure (if feasible) is important in order 
to strengthen the reliability of the data. Self-report measures may suffice in assessing 
psychological distress but clinical interviews may better capture their psychological state. 
For example, mothers reported less psychological distress symptomology on self-report 
measures than during clinical interviews (Parcells, 2010). 
 Disentangling the effects and severity of the components of psychological distress 
on maternal outcomes such as hypertension during pregnancy is warranted. However, 
future studies should be robust in design. 
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Table 4.1. Studies on the relationship of at least two psychological stress factors (stress, anxiety, and/or depression) with the 
development of a hypertensive disorder during pregnancy 
Author(s), 
year; Title 
Setting/Design 
Sample/time 
point of 
assessment 
Measure(s) Results 
Strengths 
(Salvador-Moys 
et al.) and 
limitations (2) 
Control 
variables 
Anderson, L., 
Sundstrom-
Poromaa, I., 
Wulff, M., 
Astrom, M., & 
Bixo, M. 
(2013) 
Sweden/ 
prospective 
descriptive 
N = 1495; 16-
18 weeks 
gestation 
Primary Care 
Evaluation of 
Mental 
Disorders, self-
report 
Depressive 
disorders were most 
common, 
prevalence 11.6%; 
anxiety prevalence 
6.2%; no 
correlations 
between depression 
and/or anxiety and 
a hypertensive 
disorder 
2. Sample size too 
small to detect 
rare adverse 
events 
2. Assessed at one 
time point 
2. Excluded 
women were of 
lower 
socioeconomic 
status 
Age, parity, 
marital status, 
socioeconomic 
status, 
smoking, pre-
pregnancy 
BMI, chronic 
disease, history 
of miscarriage 
Franco, R. C., 
Ferreira, C. R., 
Vieira, C. R., 
& Silva, R. R. 
(2015) 
Brazil/Cross 
sectional 
N = 105; 28 
weeks to birth 
State-Anxiety 
Inventory and a 
clinical-
behavioral 
questionnaire, 
self-report 
There was a 
difference between 
those with anxiety 
and the 
development of 
hypertension (p = 
0.049);  
Same for 
depression (p = 
0.011) 
Depression 
increased likelihood 
of hypertension  
 
1. Higher levels of 
anxiety have been 
seen in 3rd 
trimester 
2. Information in 
text does not 
match with 
information in 
tables 
2. Analysis does 
not match up with 
tables presented 
2.Small sample 
size 
Not specified 
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Table 4.1 (Continued). Studies on the relationship of at least two psychological stress factors (stress, anxiety, and/or depression) 
with the development of a hypertensive disorder during pregnancy 
Author(s), 
year; Title 
Setting/Design 
Sample/time 
point of 
assessment 
Measure(s) Results 
Strengths 
(Salvador-Moys 
et al.) and 
limitations (2) 
Control 
variables 
    (OR 8.69; CI 1.19 – 
63.42, p = 0.033) 
Anxiety increased 
likelihood of 
hypertension (OR 
7.77; CI 1.19 – 
50.45, p = 0.032) 
2. Assessed at one 
time point 
2. Did not provide 
reliability/validity 
of instruments or 
cut points used 
2. A hypertensive 
disorder could not 
be determined 
because blood 
pressure was 
assessed only 
once 
 
Kurki, T., 
Hiilesmaa, V., 
Raitasalo, R., 
Mattila, H., & 
Ylikorkala, O. 
(2000) 
Finland/prospe
ctive 
N = 623; 10-17 
weeks gestation 
and at birth 
Modified Beck 
Depression 
Inventory and 
one question 
about anxiety 
(“Are you tense 
or distressed?”), 
self-report 
Depression (>4.5 in 
BDI) in 30%; 
anxiety in 16%; 
OR for 
preeclampsia in 
women with 
depression = 2.5, 
with anxiety = 3.2, 
combined = 3.1 
1. Depression and 
anxiety were 
assessed prior to 
signs of 
preeclampsia 
2. Assessed at one 
time point 
2. Small sample 
size 
1 or 2. Cohort 
included one 
demographic 
Age, marital 
status, bacterial 
vaginosis, 
smoking, 
alcohol use, 
and profession 
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Table 4.1 (Continued). Studies on the relationship of at least two psychological stress factors (stress, anxiety, and/or depression) 
with the development of a hypertensive disorder during pregnancy 
Author(s), 
year; Title 
Setting/Design 
Sample/time 
point of 
assessment 
Measure(s) Results 
Strengths 
(Salvador-Moys 
et al.) and 
limitations (2) 
Control 
variables 
Qui, C., 
Williams, M. 
A., Calderon-
Margalit, R., 
Cript, S. M., 
& Sorensen, 
T. (2009) 
US/retrospectiv
e 
N = 2601; 
pregestational 
and prior to 20 
weeks gestation 
Medical records 
and self-reported 
medical histories 
Prevalence of 
depression, bipolar 
or anxiety 5.2% of 
that 22% were 
diagnosed during 
first 20 weeks 
gestation; 
Depression, bipolar 
or anxiety had RR 
for preeclampsia 
was 2.86 p = 0.003, 
adjusted RR was 
2.12 p = 0.045; 
Depression or 
bipolar had RR 
2.72 p = 0.009; 
disorders diagnosed 
during the first 20 
weeks were more 
strongly related 
with preeclampsia 
risk with adjusted 
RR was 3.64 p = 
0.030 
1. Assessed prior 
to signs of 
preeclampsia  
2. Two few 
isolated anxiety or 
comorbid cases to 
estimate 
preeclampsia risk 
2. 87.5% of those 
with 
psychological 
disorders were on 
medications, 
authors did not 
assess risks for 
those not on 
medication 
2. Use of medical 
records to obtain 
mental health 
status but no 
mention of 
specific 
instrument used in 
screening 
Age, race, 
income, parity, 
marital status, 
diabetes, 
hypertension, 
employed, 
alcohol use, 
exercise, pre-
pregnancy 
BMI (altered 
unadjusted 
relative risks 
by ≥ 10%); 
adjusted RR 
included age, 
race, and pre-
pregnancy 
BMI 
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Table 4.1 (Continued). Studies on the relationship of at least two psychological stress factors (stress, anxiety, and/or depression) 
with the development of a hypertensive disorder during pregnancy 
Author(s), 
year; Title 
Setting/Design 
Sample/time 
point of 
assessment 
Measure(s) Results 
Strengths 
(Salvador-Moys 
et al.) and 
limitations (2) 
Control 
variables 
     2. Low prevalence 
of psychological 
disorders, possible 
cases undetected 
2. Small sample 
size (only 9 
subjects with 
preeclampsia and 
any psychological 
disorder) 
 
Sikkema et al. 
(2001) 
Netherlands/ 
prospective 
case control 
matched for 
BMI, age, 
smoking, 
medication, 
race, parity, 
history of 
miscarriage, 
preeclampsia, 
diabetes or 
hypertension 
N = 18 women 
(9 who 
developed 
preeclampsia 
and 9 matched 
controls); 17-18 
and 27-28 
weeks gestation 
State-Trait 
Anxiety 
Inventory (Dutch 
version) and 
Pregnancy-
related Anxiety 
Questionnaire, 
self report; 
salivary cortisol 
Prevalence of 
anxiety was 3.6%; 
Stress as evident by 
salivary cortisol 
levels was not 
different between 
cases and controls; 
there were no 
differences in state, 
trait, or pregnancy-
specific anxiety 
scores and the 
development of 
preeclampsia  
1 or 2. All white 
women 
2. Small sample 
size 
2. Anxiety scores 
were low except 
for 1 
2. Perceived stress 
was not assessed 
and may have an 
effect 
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Table 4.1 (Continued). Studies on the relationship of at least two psychological stress factors (stress, anxiety, and/or depression) 
with the development of a hypertensive disorder during pregnancy 
Author(s), 
year; Title 
Setting/Design 
Sample/time 
point of 
assessment 
Measure(s) Results 
Strengths 
(Salvador-Moys 
et al.) and 
limitations (2) 
Control 
variables 
    between cases and 
controls 
  
Thombre, M., 
Talge, N., & 
Holzman, C. 
(2015) 
US/ 
retrospective 
N = 1371; 
lifetime history, 
one year prior 
to pregnancy, 
since last 
menstrual 
period, and 
within the past 
week; 16-17 
weeks gestation 
Center for 
Epidemiologic 
Study 
Depression 
scale, self-report 
and medical 
report of 
antidepressant/ 
antianxiety 
medication 
prescription 
during 
pregnancy 
Prevalence of 
depressive 
symptoms during 
past week was 
35%; depressive or 
anxiety symptoms 
since last menstrual 
period was 5%; 
depressive or 
anxiety symptoms 
in past week or 
since last menstrual 
period were not 
significant risk 
factors in the 
development of 
hypertensive 
disorders 
1. Demographic 
characteristics 
were well 
distributed 
2. Last assessment 
was in mid 
pregnancy so any 
changes after 
were not captured 
2. Details of 
instrument used 
were not provided 
2. Anxiety was 
not assessed with 
reliable and valid 
instrument so 
level of anxiety 
was unknown 
Age, race, 
smoking 
history, 
Medicaid 
Insurance, and 
pre-pregnancy 
BMI 
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Table 4.1 (Continued). Studies on the relationship of at least two psychological stress factors (stress, anxiety, and/or depression) 
with the development of a hypertensive disorder during pregnancy 
Author(s), 
year; Title 
Setting/Design 
Sample/time 
point of 
assessment 
Measure(s) Results 
Strengths 
(Salvador-Moys 
et al.) and 
limitations (2) 
Control 
variables 
Vollebregt, K. 
C., van der 
Wal, M. F., 
Wolf, H., 
Vrijkotte, T. 
G. M., Boer, 
K., & Bonsel, 
G. J. (2008) 
Netherlands/ 
prospective 
cohort 
N = 3679; > 24 
weeks gestation 
Work 
Experience and 
Appreciation 
Questionnaire, 
State-Trait 
Anxiety 
Inventory, 
Center for 
Epidemiological 
Studies 
Depression 
Scale, and 
Pregnancy-
related Anxiety, 
self-report 
Workstress, 
anxiety, pregnancy-
related anxiety or 
depression had no 
effect on the 
incidence of a 
hypertensive 
disorder 
1. Assessed four 
categories of 
psychological 
disorders with 
well-validated 
questionnaires 
2. Assessed in 
beginning of 
pregnancy prior 
to signs of 
preeclampsia 
2. Only assessed 
at one time point 
2. All data was 
self-reported 
Age, marital 
status, pre-
pregnancy 
BMI, chronic 
hypertension 
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Figure 4.1. PNI Framework in Pregnancy: Pathways Linking Psychological Distress, 
Immune Function, and Perinatal Health Outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Greater exposure to objectively stressful events or stressors results in greater experience 
of psychological distress (A). This effect is moderated by coping resources, including 
social support (B). Psychological distress may affect immune function via health 
behaviors (C) and direct physiological pathways (D) via effects on neuroendocrine and 
the sympathetic nervous system. In turn, immune parameters may affect maternal health 
(e.g., hypertensive disorders, susceptibility to infectious illness, wound healing), birth 
outcomes, and fetal development (E).  
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Figure 4.2. Design Diagram for Articles Included in Review    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
# of records identified from search 
= 152 
# of records after inclusion criteria 
applied and duplicates removed = 129 
# of records after titles and 
abstracts screened = 27 
# of records after full article 
review assessed against inclusion 
criteria = 4 
# of full-text articles 
screened and excluded 
= 23 
Reason for exclusion: 
Measures were 
postpartum or 
preconception 
Measured infant 
outcomes 
Only included one 
component of 
psychological stress 
Substance use including 
tobacco 
Associated with rape, 
IPV, or a natural 
disaster 
Hypertensive disorders 
in pregnancy were not 
the outcome measured 
# of studies included in systematic 
review = 7 
# of 
additional 
records = 3 
 83  
 
Chapter V: Determining Psychological Distress During Pregnancy and Its 
Association with the Development of a Hypertensive Disorder 
 
Introduction 
Hypertensive disorders in pregnancy include several classifications such as 
chronic hypertension, gestational hypertension, preeclampsia, and chronic hypertension 
with superimposed preeclampsia. These high-risk disorders complicate 5-10% of all 
pregnancies in the United States and are associated with increased maternal and fetal 
morbidity and mortality (American College of Obstetricians and Gynecologists, 2013).  
Maternal morbidity associated with a hypertensive disorder during pregnancy includes 
acute renal failure, acute liver injury, seizures, pulmonary edema, hemolysis, and 
thrombocytopenia (Ramma, 2011). Fetal morbidity is related to preterm birth and 
intrauterine growth restriction, fetal weight, and low Apgar scores (Can et al., 2011; 
Mihu et al., 2015).  
 Both normal and high-risk pregnancies are characterized by psychological and 
biological changes. These changes occur in each trimester of pregnancy along with the 
pregnant woman’s response to these changes (Coussons-Read, Okun, & Nettles, 2007). 
Sometimes these changes are maladaptive or lead to distress and adverse birth outcomes 
(Roesch, Schetter, Woo, & Hobel, 2004). Psychological distress may contribute to 
adverse pregnancy outcomes by influencing biological factors leading to dysregulation of 
the maternal immune response (Lederman, 1995; Yu et al., 2013; Zhang et al., 2013). 
Prevalence of psychological distress in pregnancy has been reported between 13 and 25% 
(Çapik & Pasinlioglu, 2015) and primarily consists of stress, anxiety, and depression 
(Emmanuel & St John, 2010). The psychological component is often overlooked or not 
addressed by healthcare providers (Goodman & Tyer-Viola, 2010). Hence, it is important 
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to assess psychological distress throughout pregnancy and understand if psychological 
distress is associated with the development of a hypertensive disorder.  
 Researchers have not reached consensus regarding the association between 
psychological distress and development of a hypertensive disorder during pregnancy. 
Although many differences exist in study design, conceptual frameworks, timing of data 
collection (e.g. trimester of pregnancy), and use of different instruments to assess components of 
psychological distress contribute to varied results (Andersson et al., 2004; Franco et al., 2015; 
Kurki et al., 2000; Qiu et al., 2009; Sikkema et al., 2001; Thombre et al., 2015; 
Vollebregt et al., 2008). The primary concern is the lack of consensus of operationalized 
definitions of the components of distress.  
Stress and the Development of a Hypertensive Disorder 
 Mental stress was associated in a pooled effect with increasing the risk of 
preeclampsia (OR 1.49; CI 1.27 – 1.74, p < .001) in a meta-analysis (Zhang et al., 2013). 
Mental stress included work stress, job strain, pregnancy-related stress, life stress, 
perceived stress, and psychosocial stress. Greater perceived general lifetime stress (OR 
2.1; CI 1.6 – 2.9, p < .001), and perceived stress during pregnancy (OR 1.7; CI 1.3 – 2.2, 
p < .001) were associated with an increased risk of a hypertensive disorder (Yu et al., 
2013). In a study conducted by Vollebregt et al., the effects of stress were not detected in 
the beginning of pregnancy or during the development of a hypertensive disorder during 
pregnancy (Vollebregt et al., 2008).  
 
 
 
 85  
 
Anxiety and the Development of a Hypertensive Disorder 
 Anxiety levels differed between women with an increased blood pressure and 
those without; however, differences were not specified (Franco et al., 2015). Anxiety was 
associated with an increased risk (OR 3.2; CI 1.4 – 7.4) for a hypertensive disorder, but a 
limitation was anxiety was assessed with one question (Kurki et al., 2000). Reported 
anxiety disorders during pregnancy were also associated with an increased risk of 
preeclampsia (RR = 2.12; CI 1.02 – 4.45, p = .045) in a study of women before 20 weeks 
gestation (Qiu et al., 2009). However, this study did not control for the use of 
psychotropic medications. Four prospective studies did not support anxiety symptoms 
with the development of a hypertensive disorder (Andersson et al., 2004; Sikkema et al., 
2001; Thombre et al., 2015; Vollebregt et al., 2008). Furthermore, anxiety levels did not 
differ for those with a hypertensive disorder from those without the disorder as measured 
in the beginning and end of the second trimester (Sikkema et al., 2001). 
Depression and the Development of a Hypertensive Disorder 
Franco et al., reported a significant difference in depression levels between 
women with an increased blood pressure and those without but did not report how they 
differed (Franco et al., 2015). In a prospective study, depression was associated with an 
increased risk (OR 2.5; CI 1.1 – 5.4) for a hypertensive disorder (Kurki et al., 2000). 
However, a significant relationship was not identified in three other prospective studies 
(Andersson et al., 2004; Thombre et al., 2015; Vollebregt et al., 2008).  
Limitations to these studies included using small sample sizes in most, assessment 
timing, having a cross-sectional design, and the use of different instruments to assess 
psychological distress. Psychological distress components were measured after symptoms 
 86  
 
of a hypertensive disorder could appear (i.e. after 20 weeks gestation) thereby eliminating 
the ability to predict and possibly altering the severity of symptoms (Thombre et al., 
2015; Vollebregt et al., 2008). Furthermore, the cross-sectional design of the most of 
these studies limited the understanding of how psychological distress changes throughout 
pregnancy. Sikkema et al. strengthened their study by using a longitudinal design 
collecting data early and late in the second trimester to capture changes in anxiety levels 
(Sikkema et al., 2001).  
 This study addresses a highly significant topic, psychological distress and the 
development of a hypertensive disorder. Given the severity of these disorders both 
maternal and fetal, understanding the etiology of hypertensive disorders is an important 
objective. Researchers have not paid much attention to psychological distress with 
respect to changes and timing throughout pregnancy in association with the development 
of a hypertensive disorder. Overwhelmingly, researchers have utilized a cross-sectional 
method rather than a longitudinal method in their studies. Furthermore, it remains unclear 
whether specific components of psychological distress (e.g., stress, anxiety, and 
depression) influence the development of a hypertensive disorder. Few studies included a 
comprehensive investigation of psychological distress by including stress, anxiety and 
depression using a conceptual framework.  
Conceptual Framework 
 There is limited literature incorporating a conceptual framework to explain the 
relationship between psychological distress and a hypertensive disorder during 
pregnancy. The psychoneuroimmunology (PNI) framework illustrates connections 
between psychological distress, immunity, and pregnancy outcomes by way of the 
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sympathetic nervous system (SNS) and activation of the hypothalamo-pituitary-adrenal 
(HPA) axis (Christian, 2012; Coussons-Read et al., 2003). Perception of a stressor 
activates the SNS and HPA axis. This activation may put pregnancies at risk if the 
psychological distress is of long duration. The PNI framework will allow the researcher 
to test three hypotheses related to psychological distress during pregnancy and an 
associated with the development of a hypertensive disorder during pregnancy (Figure 
5.1). I have operationalized stressors as the pressures experienced by the mother during 
pregnancy. The response to these stressors is psychological distress. Therefore, 
psychological distress is events, situations, and emotions that negatively affect one’s 
well-being or are perceived as harmful. Additionally, the components of psychological 
distress (perceived stress, general anxiety, and depression) are on a continuum without 
distinct boundaries (Figure 5.2). Emmanuel et al. illustrated this concept with a slight 
variation. In a concept analysis, maternal distress was the concept. In this concept, the 
stressors or pressures were pregnancy-related resulting in maternal distress (Emmanuel & 
St John, 2010). My concept is psychological distress and, as opposed to maternal distress, 
it is not explicitly pregnancy-related rather psychological distress results from perceived 
stress, general anxiety or depression. The focus of this study will only be related to the 
results from stressors and not specifically what the stressors may be for that individual.  
Based on the current research and limitations of those existing studies, more 
research is warranted. Therefore, the purpose of this study was to investigate the changes 
of psychological distress using validated measures such as the Perceived Stress Scale 
(PSS), the Generalized Anxiety Disorder (GAD) scale, and the Center for Epidemiologic 
Studies Depression Scale Revised (CESD-R) assessed in pregnancy and determine if 
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there was an association with any component of psychological distress and the 
development of a hypertensive disorder using the (PNI) framework in pregnancy. 
Specific Aims 
 Aim 1. To compare psychological distress (perceived stress, general anxiety, and 
depression) between women who developed a hypertensive disorder (n = 29) and those 
who did not (n = 87). 
Hypothesis 1: Women who develop a hypertensive disorder during pregnancy will have 
higher perceived stress, general anxiety, and depression levels. 
 Aim 2. To determine whether psychological distress (perceived stress, general 
anxiety, and depression) measured prior to 20 weeks gestation with PSS, GAD, and 
CESD-R were independent predictors of a hypertensive disorder. 
Hypothesis 2: Perceived stress, general anxiety, and depression measured prior to 20 
weeks gestation will be independent predictors of a hypertensive disorder. 
Aim 3. To compare the trajectory of psychological distress (perceived stress, 
general anxiety, and depression) throughout pregnancy between normotensive women 
and those with a hypertensive disorder 
Hypothesis 3: Perceived stress, anxiety, and depression scores will be higher at the end of 
pregnancy for women experiencing a hypertensive disorder compared to women who do 
not develop the disorder.  
Approach 
Design 
This investigation was a case-control (1:3) secondary data analysis using data 
collected from the EMPOWR (Efforts to Maximize Perinatal Outcomes in Women at 
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Risk) study (Hieronymus et al., 2016), a prospective multicenter study. Prevalence of a 
hypertensive disorder for this cohort was 5.4%. This prevalence is within the reported 
values nationwide (5-10%).  
 Five prenatal clinics in Central and Eastern Kentucky served as recruitment sites. 
Three prenatal clinic sites provided EMPOWR group prenatal care and served as 
collection points at 1) prior to 20 weeks gestation; 2) during the third trimester (28 weeks 
– birth); and 3) 2-8 weeks postpartum. All enrolled subjects were receiving Medicaid 
assistance and had at least one risk factor for preterm birth based on IOM, 2007 criteria 
(Behrman & Butler, 2007). Initially, enrolled subjects provided demographic 
information, reproductive and prenatal history, psychological distress and laboratory 
assessments, and a patient intake survey. Based upon an identified risk factor for preterm 
birth either obstetric/medical conditions, tobacco use or substance abuse, obesity or 
diabetes, Hispanic, or psychosocial variables, eligible participants were placed in a 
distinct group arm specifically designed to address that risk factor. Overall psychological 
distress assessments were collected at three time points: prior to 20 weeks gestation, after 
27 weeks gestation, and postpartum. 
 Human subjects research protection was provided in the parent study. The 
EMPOWR study received approval form the University of Kentucky’s Institutional 
Review Board (IRB). Trained research team members with experience and expertise in 
maternal child health as well as full group care training addressed the potential risks.  
Subjects did not directly benefit but received standard of care treatment. Consent and 
HIPAA were required. Research materials obtained from the study were stored in a 
locked cabinet in the College of Nursing or in locked cabinets at off-site participating 
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locations. Only principal investigator or research manager transported data from off-site 
locations.  Only the principal investigator and research manager had access to all data and 
patient identifiers. The parent study included women and minorities. Spanish and English 
versions of all study materials were provided at all recruitment sites. 
Sample 
The inclusion criteria for the parent study consisted of pregnant women ≥ 14 
years of age, less than 30 weeks gestation, on Medicaid, and demonstration of at least one 
risk factor for preterm birth. Women were excluded if they had a history or current 
diagnoses of a mental illness. Inclusion criteria for the secondary analysis will be the 
same as the original study and the addition of those women who developed a 
hypertensive disorder during pregnancy. The cases (n = 29) for this study were women 
who developed a hypertensive disorder during pregnancy. They were matched with 
controls, n = 87, on age and parity with women who did not develop a hypertensive 
disorder during pregnancy.  
Setting 
Researchers in the parent study recruited the target population from five prenatal 
clinics throughout Kentucky, two of which were university-based clinics. The combined 
projected enrollment for the three-year study was 856. The actual enrollment was 696. 
Measures 
Three valid self-report instruments were used to measure depression levels, 
anxiety levels, and perceived stress across pregnancy in the parent study.  
Depression. Depression was measured with the Center for Epidemiologic Studies 
Depression Scale Revised (CESD-R). The CESD-R is a 10-question inventory used to 
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measure current level of depressive symptoms (Miller, Anton, & Townson, 2008; 
Radloff, 1977). Patients were asked how often during the past week they felt depressive 
symptoms. Response options were ‘rarely or none of the time,’ ‘some or a little of the 
time,’ ‘occasionally or a moderate amount of time,’ and ‘most or all of the time.’ Each 
response is scored from 0 to 3 on a scale of frequency of occurrence of symptoms; two of 
the items are reversed scored. A cumulative score is obtained by summing each item for a 
range from 0 – 30, with higher scores indicating more symptoms. A cut-off score of ≥10 
is widely used to represent ‘depressed’ (Andresen, Malmgren, Carter, & Patrick, 1994).  
The original CESD and CESD-R have demonstrated concurrent validity by 
clinical and self-report criteria and construct validity through factor analysis 
(Björgvinsson, Kertz, Bigda-Peyton, McCoy, & Aderka, 2013; Boey, 1999; Radloff, 
1977). The CES-D has demonstrated high internal consistency with Cronbach’s α 0.88 in 
a pregnant population (Radloff, 1977). The CESD-R has also demonstrated along high 
internal consistency with Cronbach’s α 0.86 in patient population, and 0.92 in general 
population (Miller et al., 2008; Van Dam & Earleywine, 2011). Acceptable ranges for 
internal consistency are between 0.3 and 0.8 (Waltz, Strickland, & Lenz, 2010). 
Components of factor analysis included: depressed mood, feelings of guilt and 
worthlessness, feelings of helplessness and hopelessness.  
Anxiety. Anxiety was measured with the Generalized Anxiety Disorder measure, 
7-item (GAD – 7). The GAD-7 is a brief measure for assessing generalized anxiety and 
symptom severity (Spitzer et al., 2006). Patients are asked how often during the last two 
weeks they were bothered by each of the symptoms. Response options were ‘not at all,’ 
‘several days,’ ‘more than half the days,’ and ‘nearly every day.’ Scores were 0, 1, 2, and 
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3, respectively. Summed scores range from 0 – 21 with higher scores indicated higher 
levels of anxiety and/or symptom severity (Spitzer et al., 2006). The GAD-7 yielded a 
sensitivity (true positive) of 73.3% and specificity (true negative) of 67.3% at a cut-off 
score of 7 in pregnancy (Zhong et al., 2015). 
The internal consistency of the GAD-7 was excellent with a Cronbach’s α 0.92 in 
a general patient population (Spitzer et al., 2006) and 0.89 in a pregnant population 
(Zhong et al., 2015). Validity was established with factor analysis as well as convergent 
validity with correlations with Beck Anxiety Inventory (r = 0.72) and the anxiety 
subscale of the Symptom Checklist – 90 (r = 0.74) (Spitzer et al., 2006). Convergent 
validity is claimed if r is above 0.70 (Waltz et al., 2010). 
Stress. Stress was measured with the Perceived Stress Scale, 4-item (PSS – 4). 
The Perceived Stress Scale PSS is a questionnaire developed by Cohen et al. to evaluate 
the degree to which an individual perceives life situations as stressful. The PSS is one of 
the most widely used instruments for measuring stress (Lee, 2012). It has three forms, 4-
item, 10-item, and 14-item all created in the early 80’s (Cohen, Kamarck, & Mermelstein, 
1983). The items are answered with a 5-point Likert-scale and range from 0 (never) to 4 
(very often). Ranges for the PSS-4 are 0 to 16. Scores are summed and a higher score 
indicates greater perceived stress. The instrument was designed for use with almost any 
sub-population group due to the generality of the content. Questions reflect feelings an 
individual experienced over the past month. 
Initial validation methods of PSS conducted by Cohen et al. consisted of two 
groups of college students and a group enrolled in a smoking cessation program (1983). 
Internal consistencies using Cronbach’s α were 0.84, 0.85, and 0.86 in each of the 
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samples (Cohen et al., 1983). In addition, test-retest correlation in a sample of college 
students was 0.85, whereas the correlation was only 0.55 for the smoking cessation group 
(Cohen et al., 1983). Construct validity was assessed through correlations between the 
PSS and Life-Event Scores. Small to moderate correlations between the impact of life 
events and the PSS in college student samples 1 and 2, along with smoking-cessation 
groups at beginning and end of treatments were evident (0.35, 0.24, 0.49, 0.33, 
respectively, p < .01) (Cohen et al., 1983). PSS has also been used to measure subjective 
stress among pregnant women (Liou, Wang, & Cheng, 2014; Parcells, 2010) but only one 
study reported internal consistency with Cronbach’s α 0.80 (Hayase, Shimada, & Seki, 
2014). 
Demographic Characteristics and Survey Variables 
 Demographic data were collected through self-report (race, parity, marital status, 
educational level, BMI, and tobacco use) or medical record (Wager & Jefferson) at the 
initial visit prior to 20 weeks gestation in the parent study.  
Procedures 
 An exemption certification was obtained from the University of Kentucky IRB for 
this study as de-identified data from a data repository was used. Data were obtained and 
sorted to include a group of women who developed a hypertensive disorder during 
pregnancy. In addition, data were filtered at each trimester to account for any missing 
data. Andersen et al., recommends using mean imputation to replace one missing score if 
needed (Andresen et al., 1994). If necessary, data was transformed to obtain a normal 
distribution. Continuous data was used if normalizing is possible. If normalizing the data 
is not possible, data was categorized prior based on set cut-off points from previous 
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studies. Means and standard deviations were reported as original non-transformed 
variables. 
Analysis 
 Descriptive statistics were used to characterize the participants in the secondary 
analysis. Bivariate analysis including t-test and chi-square test were used to compare 
between the two groups (women with a hypertensive disorder and those without) to 
determine whether there were differences in sociodemographic variables. Results will be 
reported as mean ± standard deviation or number (n) and percent (%). All analysis will be 
conducted with SPSS version 22 (Amonk, NY). A priori significance level is p = 0.05. 
Aim 1. To compare psychological distress (perceived stress, general anxiety, and 
depression) between women who developed a hypertensive disorder (n = 29) and those 
who did not (n = 87). Comparisons of differences of means between groups were 
measured with independent t-tests or Mann-Whitney for nonparametric data. Results 
were reported as means and standard deviations.  
Aims 2.To determine whether psychological distress (perceived stress, general 
anxiety, and depression) measured prior to 20 weeks gestation with PSS-4, GAD-7, and 
CESD-R were independent risk factors in the development of a hypertensive disorder. 
Logistic regression analysis was used to determine if the presence of depression, anxiety, 
or perceived stress measured early in pregnancy were risks in the development of a 
hypertensive disorder. Adjustments were made for the following known risk factors that 
influence the development of a hypertensive disorder during pregnancy:  BMI, race, and 
smoking status (Sibai et al., 1997) and adjusted odds ratios were reported. The sample 
size of 116 was sufficient to meet the suggested 10-15 cases of data for each variable in 
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the model (Field, 2009). Assumptions in this analysis were depression, anxiety, and 
perceived stress were independent variables. If multicollinearity existed, adjustments 
were made either through measuring the interaction effect or centering each variable. If 
data were severely skewed, cut points were used to create dichotomous variables. 
Aim 3. To compare the trajectory of psychological distress (perceived stress, 
general anxiety, and depression) throughout pregnancy between normotensive women 
and those with a hypertensive disorder. In order to assess changes over time, repeated 
measures ANOVA was performed to explore changes in depression, anxiety, and 
perceived stress as reported in the CESD-R, GAD-7, and PSS-4 instruments for those 
with a hypertensive disorder compared to the normotensive group.  
Results 
Patient Characteristics 
 Per study design, the sample consisted of 29 (25%) pregnant women with a 
hypertensive disorder and 87 (75%) without the disorder. The average age for the group 
was 23 years old. The majority of the sample was not Caucasian (68%). The majority, 
86%, had a high school degree, equivalent, or less. More of the sample were married or 
living with their partner (57%) than single or not living with their partner (43%). Thirty-
four percent of the sample reported smoking three months prior to pregnancy. There were 
no significant differences between hypertensive and normotensive demographic or social 
characteristics for this sample of women with the exception of BMI. In this sample, 
women with a hypertensive disorder had a significantly higher BMI than normotensive 
women. Table 5.1 provides patient characteristics of this sample. 
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Specific Aim 1 – Comparison of Distress Between Groups 
 Data were checked for normality. As the data were close to a bell-shaped curve 
and the sample size was sufficient, normal theory based test were used throughout the 
analysis. Independent t-tests compared distress scores between women who developed a 
hypertensive disorder in pregnancy with normotensive women. Scores measuring 
depressive symptoms, perceived stress, and symptoms of anxiety in early and late 
pregnancy were compared between groups. There were no significant differences 
between normotensive and hypertensive women at any of the time points. Tables 5.2 and 
5.3 provide the comparisons (mean ± SD) of the two groups.  
Specific Aim 2 – Independent Predictors of Developing a Hypertensive 
Disorder 
 Multivariate logistic regression was used to determine if any the study variables 
were independent predictors for the development of a hypertensive disorder. Prior to 
running the analysis, the assumptions were checked and multicollinearity was not a 
factor. Smoking status, race, and BMI were included as they are known to be associated 
in the development of a hypertensive disorder of pregnancy (Paré et al., 2014; B. D. 
Sibai, Gus; Kupferminc, Michael, 2005). The three variables of distress as measured by 
the CESD-R, PSS-4, and GAD-7 were also included to test the predictability of these 
factors. There was a significant association between BMI and the development of a 
hypertensive disorder of pregnancy. For every unit increase in BMI, there was a 13% 
increase in developing a hypertensive disorder. Table 5.4 illustrates the multivariate 
model. 
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Specific Aim 3 – Changes in Distress Variables by Time 
 Repeated measures ANOVA resulted in no significant main effects of difference 
over time or by hypertensive status for CESD-R, PSS-4, or GAD-7 scores. The 
interaction between time and hypertension was not significant in the model.  
Discussion 
 The results of the present study do not support psychological distress as a 
contributing factor to the development of a hypertensive disorder during pregnancy. 
Depressive symptoms, perceived stress, and symptoms of anxiety were not different 
between groups early in pregnancy. This finding is similar to Sikkema et al., reporting no 
differences in State-Trait Anxiety Inventory scores between normotensive and 
hypertensive women (Sikkema et al., 2001). Yu et al. reported different results when 
assessing perceived stress during pregnancy. The researchers stated women with 
preeclampsia has higher levels of perceived stress during pregnancy than women without 
the disorder (Yu et al., 2013). Perceived stress was measured with one question differing 
from the PSS-4 used in this study and may have accounted for this difference. Lastly, 
Kim et al., reported a difference in depression symptoms as measured early in pregnancy 
with the Edinburgh Postnatal Depression Scale (EPDS) between a sample of African-
American women with a hypertensive disorder and women without the disorder (Kim et 
al., 2013).    
 In addition, results of the present study do not suggest any component of 
psychological distress early in pregnancy is associated with the development of a 
hypertensive disorder. This finding is similar to studies (Andersson et al., 2004; Sikkema 
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et al., 2001; Vollebregt et al., 2008). Andersson, et al., did not find significant 
associations in depressive and anxiety disorders with the development of a hypertensive 
disorder using the Primary Care Evaluation of Mental Disorders. Vollebregt et al., did not 
find associations of work stress, anxiety, or depression measured early in pregnancy and 
the development of a hypertensive disorder later in pregnancy (Vollebregt et al., 2008). 
Similarly, Sikkema et al., did not support an association of anxiety with the development 
of preeclampsia using the State-Trait Anxiety Inventory (Sikkema et al., 2001). However, 
Kurki et al., reported in a study on preeclampsia a significant association between the 
disease and antenatal depressive and/or anxiety symptoms (Kurki et al., 2000). This 
difference could be due to the instruments used in assessing depressive symptoms, i.e. 
CESD-R in this study compared to Beck Depression Inventory and GAD-7 in this study 
compared to one question used to assess the presence of anxiety. Thrombre et al., also 
reported associations between maternal depression or anxiety symptoms and hypertensive 
disorders of pregnancy but these associations were driven primarily by the presence of 
chronic hypertension (Thombre et al., 2015). 
Body mass index (BMI) was an independent predictor in the development of a 
hypertensive disorder. This finding has been supported in other studies. In a sample of 
2637 women being overweight or obese was the most important risk factor with an 
adjusted odds ratio 1.65; 1.13-2.41 for BMI 25-30 (Paré et al., 2014). Furthermore, as 
BMI values increase above the normal weight range, they were associated with a higher 
likelihood of major depression in pregnancy (Bodnar, Wisner, Moses-Kolko, Sit, & 
Hanusa, 2009). In addition, women with a BMI above the normal weight were 
significantly more likely to have depression and/or anxiety compared to women with a 
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normal BMI (Zhao et al., 2009). Body mass index fits within the PNI framework as a 
health behavior that can influence the immunological response, specifically an 
exaggerated pro-inflammatory response. This response can thereby lead to adverse 
pregnancy outcomes such as the development of a hypertensive disorder of pregnancy 
(Ruyak & Corwin, 2013). 
There were no differences by time with any component of psychological distress 
between women with a hypertensive disorder of pregnancy and normotensive women. 
Depressive symptoms, perceived stress, and symptoms of anxiety early and late in 
pregnancy were not different between groups. Few studies have measured maternal 
psychological distress over time comparing hypertensive and normotensive women. 
Sikkema et al. reported no differences in anxiety scores between women with a 
hypertensive disorder and those without the disorder at 17-18 weeks gestation or at 27-28 
weeks gestation.  
Limitations 
 Limitations for this study include being a secondary data analysis, sample size, 
and the presence of bias. As a secondary data analysis, the researcher has no control of 
the parent study sample population. The development of a hypertensive disorder was not 
the primary focus of the parent study; therefore, they did not screen potential participants 
for high risk factors for the development of a hypertensive disorder. Another limitation is 
the small sample size of participants that met the criteria of a hypertensive disorder. The 
presence of recall bias with this type of study could also be a limitation. The 
questionnaires used to assess psychological distress were based on participant’s 
recollection of feelings of stress, anxiety, and depression; therefore, an inaccurate 
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assessment of their symptoms may have occurred. Memory errors such as forgetting 
result in under-reporting (Adams, Soumerai, Lomas, & Ross-Degnan, 1999). The use of 
self-report measures may not accurately reflect the actual level of psychological stress in 
part due to social desirability bias. Social desirability bias occurs when an individual 
reports the socially desirable behavior when questioned (Adams et al., 1999). There is a 
societal norm that the experience of pregnancy is a happy and joyful time in life so 
women experiencing psychological distress may under-report their symptoms or severity 
(Dunkel Schetter, 2011). Sampling bias is a systematic error in sampling procedures that 
can distort the results of a study. The most common type of sampling bias is non-
response bias. This occurs when the people refuse to participate in a study and those non-
respondents are different from those that responded and this difference is not captured 
(World Health Organization, 2014). The parent study projected a 25% enrollment rate 
indicating a 75% non-response rate. If there are differences between these two groups, 
study results will not generalizable outside of the study population. 
Future Research 
 Future research should consider the use of prospective, longitudinal studies with 
large sample sizes using a conceptual framework, valid instruments and a biological 
measure. The PNI Framework in Pregnancy can serve as a model for future studies. 
Using the PNI Framework in Pregnancy, stressors can be evaluated as well as 
determining the mediating effects of coping mechanisms to identify areas where nursing 
interventions could provide the most influence. For example, after evaluating a stressor, 
nurses or healthcare providers could assist the pregnant mother to identify sources of 
social support thereby possibly reducing the psychological distress. Another example 
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would be in identifying the psychological distress and help the pregnant woman modify 
health behaviors such as diet and sleep. The PNI Framework allows for assessments of 
stressors, coping mechanisms, psychological distress responses, modifiable behaviors 
associated with these psychological distress responses, and the effects on inflammatory 
response and/or maternal outcomes such as the development of a hypertensive disorder 
during pregnancy. In addition to evaluating psychological distress during pregnancy with 
self-report measures, the use of a biomarker confirmation of stress, anxiety, and 
depression would strengthen the reliability of the findings. These methods should be 
included in future studies. 
Conclusion 
 This was one of the first longitudinal studies thoroughly evaluating the 
components of psychological distress using valid instruments and a theoretical 
framework. The framework provided a foundation to test three hypotheses. In this 
population, they hypotheses tested were not supported and psychological distress was not 
different between women with a hypertensive disorder of pregnancy and those without 
the disorder. Furthermore, psychological distress did not differ early or late in pregnancy 
between these two groups. Women in both groups reported having some depressive 
symptoms, and fewer symptoms of anxiety or perceived stress. In addition, the 
components of psychological distress were not independently associated with the 
development of a hypertensive disorder of pregnancy. This study did compliment other 
evidence reporting BMI as an independent risk factor in the development of a 
hypertensive disorder during pregnancy.  
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 Investigating these modifiable risk factors in the development of a hypertensive 
disorder should continue to be a research priority. Longitudinal research studies with 
larger sample sizes and using the PNI framework is warranted in order to better 
understand the role of these variables in the development of this adverse pregnancy 
outcome. 
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Table 5.1. Sample characteristics of women with a hypertensive disorder compared to 
normotensive women (n = 116) 
Characteristic 
Hypertensive 
Disorder 
Normotensive p-value 
Age; mean ± SD 23 ± 5.4 22.7 ± 5.6 .793 
BMI; mean ± SD 31 ± 1.7 27 ± 0.8 .019* 
Race 
Caucasian; n, % 
Not Caucasian; n, % 
 
12 (41.4%) 
17 (58.6%) 
 
25 (28.7%) 
62 (71.3%) 
.251 
Education 
High school or less; n, % 
Greater than high school; n, % 
 
22 (75.9%) 
7 (24.1%) 
 
78 (90.7%) 
8 (9.3%) 
.134 
Relationship Status 
Single/not living with partner; 
n, % 
Married/living with partner; n, 
% 
 
13 (44.8%) 
16 (55.2%) 
 
37 (42.5%) 
50 (57.5%) 
.819 
Smoking Status 3 mo. prior to 
pregnancy 
Yes; n, % 
 
5 (21.7%) 
 
34 (39.5%) 
.145 
*significant to ≤ .05 
 
Table 5.2. Comparison of distress scores between normotensive women and women 
with a hypertensive disorder of pregnancy early in pregnancy 
Measure of Distress Hypertensive (n = 
29) 
Normotensive (n = 
87) 
p-value 
CESD-R (mean ± SD) 10.78 ± 6.81 10.55 ± 7.62 .885 
PSS-4 (mean ± SD) 5.61 ± 2.56 5.31 ± 3.20 .654 
GAD-7 (mean ± SD) 5.75 ± 4.93 5.32 ± 4.71 .679 
 
 
Table 5.3. Comparison of distress scores between normotensive women and women 
with a hypertensive disorder of pregnancy late in pregnancy 
Measure of Distress Hypertensive (n = 
16) 
Normotensive (n = 
45) 
p-value 
CESD-R (mean ± SD) 9.74 ± 7.08 10.59 ± 8.03 .709 
PSS-4 (mean ± SD) 5.88 ± 2.78 5.80 ± 3.23 .935 
GAD-7 (mean ± SD) 5.12 ± 4.46 5.67 ± 5.14 .699 
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Table 5.4. Multivariate model for development of a hypertensive disorder of pregnancy 
 Odds Ratio 95% Confidence 
Interval 
p-value 
CESD-R .888 .763 - 1.033 .125 
PSS-4 1.240 .915 - 1.680 .165 
GAD-7 1.171 .958 - 1.433 .123 
Smoking .504 .116 - 2.182 .360 
Race 1.449 .347 - 6.044 .611 
BMI 1.131 1.042 - 1.229 .003* 
*significance to ≤ .05 
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Figure 5.1. PNI Framework in Pregnancy: Pathways Linking Psychological Distress, 
Immune Function, and Perinatal Health Outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Greater exposure to objectively stressful events or stressors results in greater experience 
of psychological distress (A). This effect is moderated by coping resources, including 
social support (B). Psychological distress may affect immune function via health 
behaviors (C) and direct physiological pathways (D) via effects on neuroendocrine and 
the sympathetic nervous system. In turn, immune parameters may affect maternal health 
(e.g., hypertensive disorders, susceptibility to infectious illness, wound healing), birth 
outcomes, and fetal development (E). 
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Figure 5.2. Concept of Psychological Distress on a Continuum 
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Chapter VI: Conclusions and Discussions 
 
Synthesis of Findings and Implications 
The purposes of this dissertation were to: 1) understand the experience of having 
a hypertensive disorder during pregnancy; 2) to investigate the association of perceived 
stress and changes in immune response via biomarker measures in women who develop a 
hypertensive disorder during pregnancy; 3) to review, summarize, and evaluate the 
literature examining the relationship between perceived maternal distress (stress, anxiety, 
and depression) and the development of a hypertensive disorder; and 4) to investigate the 
association of perceived distress in the development of a hypertensive disorder during 
pregnancy. In this dissertation, four studies were presented. The first was a qualitative 
descriptive design used to provide a comprehensive summary of the experience of being 
placed on bed rest for a hypertensive disorder, specifically preeclampsia and to identify 
the key stressors these women experienced. Seven women met the inclusion criteria for 
this study. After transcription, three members of the research team performed qualitative 
content analysis. The team reached consensus with six themes emerging related to the 
stressors experienced by these women in this study. The stressors included negative 
thoughts and feelings, lack of guidelines and/or knowledge about their diagnosis, family 
stressors, lack of social support, not being heard, loss of normal pregnancy, and physical 
symptoms. However, the three most common stressors identified by these women were 
negative feelings, frustration with lack of guidelines related to diagnosis, and feelings of 
not being heard by their healthcare providers.  
All of the study participants described negative thoughts and feelings related to 
their experience of preeclampsia and being placed on bed rest. Some of these negative 
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feelings could be characterized as anxiety related symptoms. Participants used terms such 
as “nervous wreck” and “stressed out” to describe their experience.  
Participants also described feelings of frustration when dealing with their 
healthcare providers and the lack of evidence-based guidelines being used by their 
providers. They received “mixed messages” and their care lacked continuity between 
providers. The majority of these participants were actively educating themselves about 
their condition along with recommended treatments. Their self-education often was in 
conflict with the management of their high-risk condition.  
Lastly, these women did not feel heard by their providers. All but one of the 
women in this study reported never being asked how they felt about their high-risk 
condition or about being placed on bed rest. When they did try to communicate with their 
providers about concerns or questions, they were “brushed off”. These feelings can 
hinder the patient-provider relationship. This is reflected in the fact that six of the seven 
women did not report a positive relationship with their provider. Interventional research 
should focus on improving psychosocial wellness during a high-risk pregnancy.  
In the second study, the author explored the association of everyday stress and 
inflammatory response with the development of a hypertensive disorder during 
pregnancy. This was a secondary data analysis of a longitudinal, repeated measures, 
multicenter study of healthy pregnant women. Data collected from the parent study were 
matched on age and parity in a 1:2 case control design. Cases consisted of women 
diagnosed with a hypertensive disorder during pregnancy (n = 33), while controls 
consisted of women without a hypertensive disorder (n = 64). Prenatal stress was 
measured through the ESI and systemic inflammation was measured using serum 
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inflammatory biomarkers including both pro- and anti-inflammatory cytokines. High 
levels of stress altered inflammatory response in each trimester of pregnancy in both 
women with a hypertensive disorder and those without the disorder.   
Repeated measures models showed significant main effects of stress level 
(high/low) and hypertension status for IL-8. Serum levels of IL-8 were reduced in those 
with high stress compared to women with low stress. In addition, there was an interaction 
effect of stress level by trimester for IL-1α. Women with high stress had lower levels of 
IL-1α in the first trimester compared to women with low stress in the same trimester. 
Lastly, a significant difference in the change of serum IL-10 levels was identified with 
the interaction effect of stress level and a having a hypertensive disorder by trimester. 
Third trimester serum levels of IL-10 were significantly higher in women with high stress 
and a hypertensive disorder compared to normotensive women with low stress levels. 
Previous research has supported alterations in maternal inflammatory response in 
women with a hypertensive disorder during pregnancy. Increased serum cytokines IL-6, 
IL-1α, IL-1β, and IL-8 have been reported in late pregnancy (Ramma, 2011; Szarka et al., 
2010). However, the current research did not support this association. 
Research has also supported alterations in maternal inflammatory response 
associated with psychological stress, specifically high stress was associated with higher 
levels of serum inflammatory markers (Coussons-Read et al., 2007). However, the 
finding of this study did not support prior research. Women with low stress scores had 
higher levels of inflammatory markers than women with high stress in this study.  
Lastly, women experiencing a hypertensive disorder and high levels of stress had 
higher levels of serum IL-6 in all trimesters. This was a similar finding to Coussons-Read 
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et al. (2005). Serum levels of IL-10, an anti-inflammatory marker, were significantly 
higher in the third trimester in women with high stress and a hypertensive disorder. This 
could be a compensatory mechanism. Additional research is needed to better understand 
the maladaptation of the maternal immune response in the presence of a heightened stress 
response and a hypertensive disorder during pregnancy. 
The third study was a critical examination of current literature that studied the 
relationships of psychological distress (stress, anxiety, and depression) with the 
development of a hypertensive disorder during pregnancy. Seven English-language, peer-
reviewed articles published between January 2008 and 2016 met inclusion criteria for 
review. From this review, findings with respect to an association between psychological 
distress and a hypertensive disorder were mixed. For example, significant positive 
associations were reported between a measure of psychological distress and the 
development of a hypertensive disorder during pregnancy in three of the reviewed studies 
(Franco et al., 2015; Kurki et al., 2000; Qiu et al., 2009). While other researchers did not 
support this finding (Andersson et al., 2004; Sikkema et al., 2001; Thombre et al., 2015; 
Vollebregt et al., 2008). Gaps were discovered with respect to the role of psychological 
distress in the development of a hypertensive disorder during pregnancy primarily in 
study design, use of conceptual framework, and instruments utilized. Future studies 
should be longitudinal in design, utilize a conceptual framework, and include the use of 
valid instruments to obtain a thorough assessment of psychological distress along with an 
accompanying biological measure.  
The fourth study examined the association of psychological distress with the 
development of a hypertensive disorder during pregnancy using the PNI framework 
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(Christian, 2012b). This investigation was a case-control (1:3) secondary data analysis. 
Data was collected from a prospective, longitudinal multicenter study of women 
receiving Medicaid with at least one risk factor for preterm birth and without a history of 
mental illness (Hieronymus et al., 2016). Data collected for the secondary study was 
frequency matched on age and parity resulting in 29 cases of women who developed a 
hypertensive disorder during pregnancy and 87 women who did not develop the disorder. 
Psychological distress (stress, anxiety, and depression) was measured twice during 
pregnancy (early and late) using valid instruments. The CESD-R assessed maternal levels 
of depressive symptoms. Symptoms of maternal anxiety were assessed using the GAD-7 
and perceived stress was assessed using the PSS-4.  
In this sample there were no differences between hypertensive and normotensive 
demographic or social characteristics with the exception of BMI. Women with a 
hypertensive disorder had a significantly higher BMI than normotensive women at 
baseline. Furthermore, contrary to hypothesized differences, there were no differences in 
depressive symptoms, perceived stress, or symptoms of anxiety between these groups at 
any time point. This finding is consistent with Sikkema et al., with no differences 
reported in anxiety scores, but varies from Yu et al., reporting higher levels of perceived 
stress in women with preeclampsia and Kim et al., reporting higher levels of depressive 
symptoms in women with a hypertensive disorder (Kim et al., 2013; Sikkema et al., 2001; 
Yu et al., 2013). 
Multivariate logistic regression examined the hypothesized independent influence 
of the variables psychological distress in the development of a hypertensive disorder 
during pregnancy. While none of the psychological distress variables were predictive in 
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development of a hypertensive disorder during pregnancy, BMI was significantly 
associated. For every unit increase in BMI, there was a 13% increase in the odds of 
developing a hypertensive disorder.  This finding related to psychological is consistent 
with other studies (Andersson et al., 2004; Sikkema et al., 2001; Vollebregt et al., 2008) 
but differed with others (Kurki et al., 2000; Thombre et al., 2015). Anderson et al., did 
not find associations in depressive or anxiety disorders with the development of a 
hypertensive disorder (Andersson et al., 2004). Work stress measured early in pregnancy 
were not associated with the development of a hypertensive disorder (Vollebregt et al., 
2008). Anxiety was not associated with preeclampsia in two studies, but was supported in 
two others (Kurki et al., 2000; Sikkema et al., 2001; Thombre et al., 2015; Vollebregt et 
al., 2008). Kurki et al., and Thombre et al., reported associations with depression and the 
development of a hypertensive disorder, while Vollebregt et al., did not find an 
association (Kurki et al., 2000; Thombre et al., 2015; Vollebregt et al., 2008). 
Body mass index as an independent predictor in the development of a 
hypertensive disorder has been supported. Not only do overweight and obese women 
have a 35% greater risk of developing of a hypertensive disorder, they are more likely to 
have depression and/or anxiety symptoms compared to women with a normal BMI (Paré 
et al., 2014; Zhao et al., 2009).   
Repeated measures ANOVA examined the hypothesized changes in trajectory of 
psychological distress throughout pregnancy for women with a hypertensive disorder 
during pregnancy. However, in this sample the hypothesis was not supported. There were 
no significant differences over time and the interaction between time and hypertension 
was not different between these groups. Currently, studies have not reported on the 
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interaction between time and hypertension. Sikkema et al., reported no differences in 
anxiety scores between women with a hypertensive disorder and those without at two 
different time points; one early and one in mid-pregnancy (Sikkema et al., 2001). Further 
longitudinal research is warranted to understand the relationship of psychological distress 
and a hypertensive disorder over time in pregnancy. 
Suggestions for Future Research 
 Few studies assess psychological components and/or biological components 
throughout a pregnancy. This is one of the first studies to explore the components of 
psychological distress and biological changes throughout pregnancy.  
 The continued use of a framework such as the PNI framework in pregnancy is 
recommended. In addition to the inclusion of psychological distress components altering 
maternal immune response and influencing prenatal outcomes, it also includes such 
potential study variables as stressors, coping resources and health behaviors (Christian, 
2012b). Studies could focus on the various components of the model to better understand 
the psychological as well as physiological changes women may undergo during 
pregnancy that lead to high-risk pregnancies and poor birth outcomes. Future research 
should utilize self-report measures of stress, anxiety, and depressive symptoms with 
biomarker confirmation. They should be longitudinal in design and incorporate large 
sample sizes due to the low prevalence of hypertensive disorders in pregnancy.  
 Implications for clinical practice are evident as well. Since increased BMI is a 
known risk factor in the development of a hypertensive disorder during pregnancy and 
was supported in this study, it is important healthcare providers assess maternal BMI and 
address this modifiable risk factor in these patients. Furthermore, although study findings 
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did not support the association of psychological distress (stress, anxiety, and depression) 
in the development of a hypertensive disorder, women having the disorder can experience 
symptoms of distress. Care for these women can be improved if healthcare providers 
assess and manage psychological wellness throughout pregnancy.  
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